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Thesis Abstract 
Background: The anatomy of the coronary venous system has important implications for 
clinical interventions including cardiac resynchronization therapy, ablation therapy, 
defibrillation, perfusion therapy, and mitral valve annuloplasty.  
Method: The effect of coronary venous anatomy on cardiac therapies was assessed by 
characterizing the venous anatomy, the clinically relevant adjacent anatomy, and the 
anatomical effect on pacing thresholds. Coronary venous anatomy was evaluated using 
perfusion-fixed human cardiac specimens with direct measurements using a microscribe 
digitizer and with contrast-computed tomography. Contrast-computed tomography and 
magnetic resonance imaging were used to investigate the coronary venous anatomical 
relationship with the phrenic nerve, coronary arteries, and mitral isthmus. Finally, 
electrostatic field simulations were performed to evaluate how cardiac anatomy and 
pacing electrode location affect clinical pacing thresholds and phrenic nerve stimulation. 
Results/Discussion: In short, the human coronary venous system is a highly variable 
physiological system that is essential for several current cardiac therapies. The consistent 
observation of high anatomical variation throughout all of the performed studies stress 
the clinical importance of understanding a given patient’s individual anatomy when 
performing a planned intervention within the coronary veins. Importantly, the database of 
coronary venous anatomical parameters and pacing thresholds presented here can be 
incorporated into the development and implementation of therapies that utilize these 
vessels. 
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 1 
1. Human Coronary Venous Anatomy Review: Implications 
for Interventions [1] 
Julianne Spencer, Sara Anderson, and Paul Iaizzo 
	  
Preface 
This review serves as an introduction to coronary venous anatomy, nomenclature, 
and clinical interventions. The majority of the content of this review is taken from an 
article published in a Special Issue on Cardiac Anatomy with the Journal of 
Cardiovascular Translational Research, edited by Paul Iaizzo, Robert Anderson, and 
Alexander Hill. My efforts involved an in-depth literature search on the anatomy and 
clinical applications of the coronary venous system. I combined my research with 
previous venous research performed by Sara Anderson from her 2008 thesis project, 
“Effects of Pacing Lead Position and Cardiac Anatomy on Left Ventricular Venous 
Pacing.” Each major coronary vein’s anatomy, nomenclature, and clinical applications 
are discussed. One reviewer referred to this paper as the current “gold standard for 
knowledge of the anatomy of the coronary venous system and its translational 
implications.” 
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Introduction 
While anatomical studies of the heart began hundreds of years earlier, Herophilus 
(c. 335-c. 280 BC) was the first to observe and record differences between coronary 
arteries and veins, including the discoveries that arteries were much thicker than veins 
and that veins, in contrast to arteries, collapsed when emptied of blood [2]. More than one 
thousand years later in 1628 AD, William Harvey published the first accurate description 
of the circulatory system [3]. Subsequently in 1689, Scaramucci documented that the 
contraction of the heart displaced blood from deeper coronary vessels into coronary veins 
[4]. However, details of coronary blood flows were not well understood until the 
technology capable of measuring arterial and venous flows was developed [4]. 
The main physiological function of the coronary veins is to return deoxygenated 
blood from the myocardium to the chambers of the heart. The majority of the return flow 
enters the coronary sinus, which drains into the right atrium. A detailed understanding of 
the complexity and relative variability within the anatomy of the cardiac venous system is 
crucial for the development of devices that require access to these vessels. For example, 
clinical applications involving the cardiac venous system include cardiac 
resynchronization therapy, ablation, defibrillation, annuloplasty, and treatment for 
coronary artery disease. 
There is high variability in the anatomy of the human coronary venous system. 
The coronary veins can be categorized into 2 subgroups: the greater and smaller cardiac 
venous system as displayed in Figure 1.1. The greater cardiac venous system is made up 
of the coronary sinus and its tributaries, as well as the anterior cardiac veins, atrial veins, 
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and the veins of the ventricular septum [5]. The smaller cardiac venous system, also 
known as the Thebesian vessels, is made up of the arterioluminal vessels and 
venoluminal vessels [5, 6]. We will provide further details regarding the veins of each 
group as well as their respective roles in current clinical applications. 
 
Figure 1.1 The greater and smaller cardiac venous system 
This tree displays the drainage configuration of the coronary systems. 
 
 
In the past, the coronary venous system and its vessels have often been described 
with varying nomenclatures. The coronary venous system itself, for example, is often 
referred to as the cardiac venous system. 
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The Greater Cardiac Venous System 
The greater cardiac venous system, also known as the major cardiac venous 
system, carries the majority of deoxygenated blood from the outer layers of the 
myocardium back to the chambers of the heart. These veins are responsible for 
approximately three-quarters of the myocardial drainage [7]. These greater cardiac veins 
are currently utilized in several clinical applications. 
 
The Coronary Sinus and its Tributaries 
The coronary sinus is the major cardiac vein that collects deoxygenated blood 
(and other waste products) primarily from the left ventricle and returns it to the right 
atrium, where it joins the systemic deoxygenated blood entering from the caval veins into 
the right atrium. The major tributaries of the coronary sinus typically include the great 
cardiac vein, the lateral veins, the inferior veins of the left ventricle, the middle cardiac 
vein, the small cardiac vein, the oblique vein of the left atrium, and sometimes the right 
marginal vein. The coronary sinus and its tributaries are displayed in Figure 1.2 along 
with their commonly used nomenclatures. 
The coronary sinus and its tributaries are currently used for the delivery of several 
clinical treatments. Currently, one of the most common uses of the cardiac venous system 
is the placement of left-sided pacing leads in cardiac resynchronization therapy. In this 
treatment, leads are permanently placed within the cardiac venous system to minimize 
delayed conduction in the left ventricle as displayed in Figure 1.3. The anatomy of these 
veins provides unique access to the myocardium of the left ventricle. A pacing lead is 
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delivered through the right atrium into the coronary sinus ostium. Therefore, a thorough 
understanding of the location, size, tortuosity, and branching angles of human venous 
anatomy is essential in designing devices to obtain optimal pacing positions in a broad 
range of individuals. 
 
Figure 1.2 3D reconstruction of the coronary veins and cardiac tissue from a 
contrast-CT of a perfusion-fixed human heart 
This is a left lateral view of the coronary sinus and its major tributaries. Some of these 
veins have varying nomenclatures present in the literature. The names highlighted in red 
are common in the literature, but are considered to be attitudinally incorrect.  
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Figure 1.3 Cardiac resynchronization therapy 
Typically, multiple leads are placed to treat dyssynchronous rhythms within the heart: 
one in the right atrium (RA lead), one in the right ventricle (RV lead), and another within 
a coronary vein (LV lead) near the latest site of activation. 
 
 
Furthermore, the coronary venous system has been used to monitor and treat 
coronary artery disease. For example, coronary arterial flow can be determined from 
within the cardiac venous system [8, 9]. Also, the coronary venous system has been 
considered to serve as an effective conduit for drug delivery or as a potential avenue for 
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coronary arterial bypass, in part due to the resistance of these vessels to atherosclerotic 
disease. For example, the administration of cardioplegia retrogradely through the 
coronary sinus has been proven to be safe and effective in myocardial protection, and 
even superior to the traditional method of antegrade cardioplegia via the coronary 
arteries, especially in patients with coronary artery disease [8, 10]. More recently, the 
administration of recombinant tissue-type plasminogen through the coronary venous 
system was shown to result in both shorter recovery times and significant reduction in 
infarct size when compared to intravenous administration [11]. 
The coronary venous system can also be employed to deliver cell therapy directly 
to the myocardium as a potential treatment for heart failure [12]. In one case study, it was 
demonstrated that a catheter-based system allowed arterialization of a cardiac vein to 
bypass a totally occluded left anterior descending coronary artery [13]. 
 
The Coronary Sinus 
As noted earlier, the coronary sinus returns the majority of the deoxygenated 
blood from the myocardium back to the right atrium. Anatomically, it is one of the most 
consistent veins of the cardiac venous system. The major cardiac veins of the left 
ventricle feed into the coronary sinus, making it the largest cardiac vein in terms of 
diameter. Various landmarks have been described as marking the beginning of the 
coronary sinus, including where the oblique vein of the left atrium meets the great cardiac 
vein, and at the valve of Vieussens, which is commonly found at the orifice of the oblique 
vein on the left margin of the heart [7, 14]. The coronary sinus continues to run on the 
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inferior region of the atrioventricular groove until it ends at its orifice located between the 
inferior caval vein and the tricuspid valve on the inferior region of the atrial septum. 
Figure 1.4 provides an image of a coronary sinus orifice obtained from within a 
reanimated human heart. 
Figure 1.4 Internal view of the coronary sinus orifice and surrounding right atrial 
wall from within an isolated functioning human heart 
 
The recording of local electrograms from within the coronary venous system can 
indicate various arrhythmias, which can be considered as potential ablation target sites 
for left-sided accessory pathways [8, 15, 16].  The coronary sinus has also been used to 
deliver ablation therapy [17-20]. To achieve ablation, a catheter can be placed within the 
coronary sinus to treat nearby identified arrhythmias. 
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In addition, a reducer stent can be placed within the coronary sinus to reduce 
chronic angina [21]. The device is placed in the coronary sinus to decrease the diameter 
of the coronary sinus in order to increase pressure in the coronary arteries. This increased 
pressure has been found to increase blood flow within ischemic areas of the heart [22-
24], which in turn can reduce angina. 
Devices for mitral valve annuloplasty devices can be similarly implanted in the 
coronary sinus. However, the use of these devices can be limited by the location of the 
circumflex artery between the valve annulus and the coronary sinus in some patients [25, 
26]. Therefore, the understanding of the anatomy of the coronary sinus and relevant 
nearby anatomical structures, such as the coronary arteries, is essential for the proper 
delivery of these clinical therapies. 
 
The Anterior Interventricular Vein and the Great Cardiac Vein 
The anterior interventricular vein commonly courses anteriorly between the left 
and right ventricle. It typically begins around the apex of the heart in the anterior 
interventricular groove and ends as it reaches the atrioventricular groove. The great 
cardiac vein is made up of the anterior interventricular vein and continues along the 
atrioventricular groove until it becomes the coronary sinus as described earlier. The great 
cardiac vein is typically the longest cardiac vein in the heart and one of the most 
consistent cardiac veins. 
Defibrillation coils have been implanted within the coronary venous system, 
specifically within the anterior interventricular and middle cardiac veins. Placement of 
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the coils within the venous system was found to lower defibrillation thresholds 
significantly [27, 28].  The lower thresholds are likely attributable to more efficient 
transfer of the defibrillation current through the heart [27].   
 
The Lateral Veins 
The veins on the free wall of the left ventricle are commonly known as the lateral 
veins, the left marginal veins, or the obtuse marginal veins. The specific location, size, 
and tortuosity of these veins vary significantly from person to person. These lateral veins 
typically originate somewhere along the left ventricular free wall and empty into the great 
cardiac vein or coronary sinus at the atrioventricular groove. 
The inferior-lateral veins most often provide the optimal pacing position for left-
sided pacing leads [29]. Knowledge of the anatomy of the lateral veins, usually achieved 
through venography, is required before commencing cardiac resynchronization therapy so 
that these pacing positions can be accessed. It is also important to understand the 
anatomy of the nearby left phrenic nerve. Currently, phrenic nerve stimulation is one of 
the prominent complications associated with left-sided pacing and has been reported to 
occur in up to two-fifths of patients undergoing cardiac resynchronization therapy [30]. 
 
The Inferior Veins of the Left Ventricle 
We consider here that the coronary veins on the inferior side of the left ventricular 
free wall should be referred to as the inferior veins of the left ventricle. Traditionally, the 
literature has referred to these veins as the posterior veins of the left ventricle. However, 
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this nomenclature is not attitudinally correct, as these veins are located on the inferior or 
diaphragmatic surface of the heart. Similar to the lateral veins, the anatomy of the inferior 
veins is also highly variable. They originate along the inferior wall of the left ventricle, 
and commonly drain into the coronary sinus. Although the lateral veins are typically used 
for left-sided pacing, the inferior veins of the left ventricle are sometimes used to place a 
pacing lead in patients where an inferior vein courses over to the left lateral side of the 
heart or patients with a conduction delay identified on the inferior wall of the left 
ventricle. 
 
The Middle Cardiac Veins 
The middle cardiac vein, also known as the inferior interventricular vein, 
commonly courses between the left and right ventricle on the inferior side of the heart. In 
the past, this vein has been referred to as the posterior interventricular vein. Again, this 
nomenclature is not attitudinally correct. The middle cardiac vein typically begins at the 
apex of the heart and courses towards the coronary sinus within the inferior 
interventricular groove. The middle cardiac vein may empty into either the coronary 
sinus or directly into the right atrium depending on the individual anatomy. The middle 
cardiac vein is also one of the most consistently present cardiac veins. As mentioned 
previously, the middle cardiac vein has been used for the placement of defibrillation 
coils. 
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The Small Cardiac Vein 
The small cardiac vein typically courses along the right atrioventricular groove. It 
drains deoxygenated blood from the right atrium and ventricle. This vein typically 
empties into the coronary sinus, but sometimes drains into the middle cardiac vein or 
directly into the right atrium. The small cardiac vein is not always present in the human 
cardiac venous system [7, 31]. The small cardiac vein has also been referred to as the 
right cardiac vein [6]. There is limited literature available on the clinical applications of 
the small cardiac vein.  
 
The Oblique Vein of the Left Atrium 
The oblique vein of the left atrium carries deoxygenated blood from the lateral 
and inferior regions of the left atrium to the atrioventricular groove. As mentioned earlier, 
the termination of this vein is an anatomical landmark for the beginning of the coronary 
sinus and the end of the great cardiac vein. The oblique vein of the left atrium has also 
been referred to as Marshall’s vein since it was first reported by John Marshall. To date, 
this vein has limited clinical applications cited in the literature [5], although its 
ligamentous remnant is often considered as a site of arrythmogenesis. 
 
The Right Marginal Vein 
The right marginal vein typically originates at or above the cardiac apex and 
courses along the free wall of the right ventricle. It is difficult to categorize the right 
marginal vein in one of the previously stated cardiac venous groups of the greater cardiac 
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venous system due to its highly variable drainage anatomy [5]. The right marginal vein 
has been cited to drain into the small cardiac vein, the middle cardiac vein, or the right 
atrium [7, 32, 33]. The right marginal vein is also known as the vein of Galen. There is 
limited literature on its current clinical applications. 
 
The Anterior Cardiac Veins 
The anterior cardiac veins carry deoxygenated blood from the right ventricle 
directly to the right atrium. These veins typically course parallel to the right margin of the 
heart [7]. There are commonly one to three large anterior cardiac veins present on the 
human heart [5, 32]. They are also known as the minor cardiac veins, the accessory 
cardiac veins, and the unnamed veins of Vieussens [5, 32]. Again, there are limited 
clinical applications involving the anterior cardiac veins in the literature. 
 
The Atrial Veins 
The atrial veins carry deoxygenated blood from the atrial tissues back to the 
cavities of the atrial chambers. The left atrial veins can be categorized into three groups 
based on the region of the left atrium that they drain: the posterolateral veins, the 
posterosuperior veins, and the septal veins [5, 7]. The posterolateral veins, including the 
oblique vein of the left atrium, course along the posteroinferior and lateral wall of the left 
atrium and empty into the coronary sinus. The posterosuperior veins of the left atrium 
were found in three-quarters of studied individuals. These vessels drain the 
posterosuperior region between the pulmonary veins and empty directly into the left 
 14 
atrium or pulmonary veins [7]. The left atrial septal veins typically drain into the right 
atrium. Anteroseptal veins have been found in almost all of examined hearts while 
posteroseptal veins were found in approximately one-third [7]. The right atrial veins are 
typically located in the intramural region of the right atrial wall and drain directly into the 
chamber. These atrial veins are considered to be a part of the greater cardiac venous 
system [5].  
 
The Ventricular Septal Veins 
The majority of deoyxgentated blood from the ventricular septum is drained 
through small septal veins that commonly empty into the great cardiac veins. More 
specifically, the anterior ventricular septal veins typically drain into the great cardiac 
vein, while the posteroinferior septal veins typically drain into the middle cardiac vein. 
The apical region of the septum is mainly drained via Thebesian vessels [7]. 
 
The Smaller Cardiac Venous System 
The smaller cardiac venous system, also known as the minor cardiac venous 
system, lesser cardiac venous system, or Thebesian vessels, are typically less than 0.5 
mm in diameter and originate from the inner layers of the myocardium [5]. These vessels 
are responsible for draining one-quarter of the deoxygenated blood used up by 
myocardium and drain directly into their respective heart chamber [7]. The majority of 
these small veins are present in the atria, although more Thebesian veins have been found 
in the right ventricle when compared to the left [34]. 
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The main types of Thebesian vessels are the arterio-luminal and veno-luminal 
vessels [7]. The arterio-luminal vessels originate from coronary arterioles or capillaries 
and empty directly into their respective heart chamber. Similarly the venoluminal vessels 
originate in coronary capillaries and venules and drain their respective heart chamber. 
The vessels that drain straight from the capillaries to the heart chamber can also be 
referred to as Thebesian trees [34, 35]. Figure 1.5 displays the typical layout of the 
smaller cardiac venous system. 
 
Figure 1.5 Drawing of the relative coronary systems present within a section 
through a wall of the heart 
The arterio-luminal and veno-luminal vessels of the smaller cardiac system drain directly 
into the chambers of the heart. 
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 Although the smaller cardiac venous system has less clinical applications relative 
to the greater cardiac venous system, it is still useful to understand the anatomy. The 
extent of these vessels could affect the delivery of nutrients or cardioplegic solutions into 
the coronary sinus [34]. The presence of these vessels will allow some of the solutions 
delivered through the coronary sinus to empty back into the heart chambers before 
reaching the capillaries. The anatomy of these vessels were reported to affect the 
perceived results of transmyocardial laser revascularization, a treatment in which a laser 
is used to create transmural pathways in the left ventricle to channel oxygenated blood to 
ischemic areas. These venous channels are similar in appearance to the smaller cardiac 
veins; so it is important to between them [34]. 
 
Venous Valves 
In general, the role of venous valves in the human body is to prevent retrograde 
blood flow. Such valves within the heart are often present at the orifice of the larger 
cardiac veins. These valves are not typically present in the smaller Thebesian veins [6]. 
Venous valves within the major left ventricular veins have a comparable number of 
valves per vein except the lateral veins, which have been reported to have fewer valves 
per vein [36]. These valves are most prevalent at the orifices to smaller contributing 
veins[36]. An example of a venous valve is presented in Figure 1.6. 
The venous valves vary considerably in their size and shape. Depending on the 
individual anatomy, these valves can impede the delivery or removal of medical devices 
within the coronary veins. Access to the major cardiac veins can be hindered by the 
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Thebesian valve, which is present at the coronary sinus orifice in over two-thirds of 
patients [37].  For example, Figure 1.7 shows a catheter caught within the Thesbesian 
valve of a reanimated human heart: this valve completely closed off the lumen during 
systole [38]. Another predominant valve, the Valve of Vieussens, can be identified at the 
delineation between the coronary sinus and the great cardiac vein [39-41]. It is prevalent 
in most patients [42] and has also been reported to obstruct catheterization of the great 
cardiac vein [43]. These valves are typically challenging to see on fluoroscopy or 
computed tomography [36], but have been identified using electron beam computed 
tomographic angiography [44] and multi-slice computed tomography [45]. 
Figure 1.6 A view of a venous valve located at the orifice of an inferior vein of the 
left ventricle 
The image was obtained using a fiberscope in the coronary sinus of a reanimated human 
heart. 
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Figure 1.7 An internal image of a mariner catheter caught in the Thebesian valve of 
an isolated functioning human heart 
 
 
Microanatomy 
In general, vessels are composed of three layers, which vary in thickness 
depending on both vessel type and their relative size [46-48]. These layers are the tunica 
intima, tunica media, and tunica adventitia, and can be seen in Figure 1.8.  The tunica 
intima is comprised of endothelium, subendothelial connective tissue, and an internal 
elastic lamina [48, 49]. The endothelium of vessels entering the heart is continuous with 
the endothelium of a given chamber [46]. In veins, the tunica intima and tunica media are 
less distinct than in arteries. The venous tunica intima is difficult to distinguish at low 
power magnification [46]. Concentric layers of smooth muscle, along with collagenic and 
elastic fibers, make up the tunica media [46-48]. The tunica media for a vein is much 
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smaller than for an artery of similar size, as can be observed in Figure 1.8 [46, 48]. The 
tunica adventitia is composed of longitudinally arranged collagen fibers [46-48] and is 
much larger in veins than in arteries [46]. 
Figure 1.8 The microanatomy of a coronary vein 
The magnification of this histology slice is 20X. Note that the tunica intima layer of the 
venous wall cannot be seen at this magnification. 
 
 
Cardiac Venous Disease 
When diseases such as heart failure induce myocardial remodeling, the venous 
system adapts to maintain both blood volume and venous pressure.  However, the 
coronary venous system is not affected by atherosclerotic disease and its “dense 
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meshwork with numerous interconnections” allows blood to return to the heart via 
numerous pathways [50]. 
 
Reported Abnormal Venous Anatomy 
As noted above, the anatomy of the human cardiac venous system is highly 
variable across patient populations. There have been reports of anatomic abnormalities of 
the cardiac veins. Most abnormalities, however, do not cause any clinical complications. 
The most commonly reported abnormality associated with the coronary veins is a 
persistent left superior caval vein. In this abnormality, the veins on the left upper side of 
the body drain into a left superior caval vein and then into the coronary sinus. The 
persistent left superior caval vein is considered to be a non-threatening anatomical 
variation, but has been associated with other congenital cardiac malfunctions. This 
abnormality is present in 0.3% of patients with normal hearts and in 4.5% of patients with 
congenital heart disease [51, 52]. 
Occlusion of the coronary sinus oriface is rare, but is well reported [53-55]. In 
these cases, the major cardiac veins are instead drained through the superior vena cava. 
Thus, treatments requiring access to the coronary sinus ostium would have to be 
delivered through the superior vena cava. It is essential to understand the individual 
patients’ anatomy before such clinical procedures are initiated. 
Some of the major cardiac veins have been reported to be duplicated [5]. For 
example, the anterior interventricular vein was observed to be duplicated in 3% of 
patients. In these patients, two large veins run parallel approximately 1mm apart along 
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the anterior interventricular groove and become one vessel at the atrioventricular groove 
[56]. The coronary sinus also was found to be duplicated with one of them in its normal 
location and the other located intramurally [57]. 
 
Assessment of the Coronary Veins 
There are various methods that can be used to assess the cardiac venous system. 
Venograms are typically used during catheterization procedures to map coronary venous 
anatomy. These are obtained by injecting contrast into the coronary sinus via a venogram 
balloon catheter under fluoroscopy as demonstrated in Figure 1.9. Computed tomography 
has been used to analyze and quantify the venous anatomy [31, 58-61]. The cardiac 
venous system has also been assessed using magnetic resonance imaging [62] and 
cadaveric specimens [63-66]. Table 1.1 summarizes the coronary venous anatomical 
measurements found in the literature. 
Figure 1.9 A venogram of a reanimated human heart 
Contrast has been injected into the coronary venous system via a venogram balloon 
catheter. 
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Table 1.1 Mean cardiac venous parameters found in the literature 
Vein Prevalence 
(%) 
Branching 
Angle (°) 
 Arc 
Length 
(mm) 
Ostia 
Diameter 
(mm) 
Sources 
Coronary 
Sinus 
100             
n=1744 
N/A 31.64 
n=569 
9.52  
n=1125 
[6, 7, 31, 58-64, 67-
80] 
Middle 
Cardiac Vein 
95        
n=783 
117           
n=231 
89.00           
n=6 
4.27         
n=554 
[31, 58-63, 66, 68, 
69, 72, 73, 75, 79-
81] 
Inferior Vein 
of the Left 
Ventricle 
82.11          
n=597 
88.9       
n=185 
23.16        
n=200 
3.00            
n=278 
[31, 58-63, 66, 68, 
72, 73, 75, 79, 81] 
Left Lateral 
Vein 
76.25                    
n=758 
85.3             
n=180 
55               
n=105.55 
2.96            
n=417 
[31, 58-63, 66, 68, 
72, 73, 75, 79-81] 
Great Cardiac 
Vein 
100                     
n=879 
N/A 133.15     
n=111 
5.21            
n=332 
[31, 58-63, 66, 68, 
72, 73, 76, 79, 80] 
Anterior 
Interventricular 
Vein 
100              
n=563 
51.4             
n=231 
89.9         
n=237 
2.87           
n=362 
[31, 58-61, 63, 68, 
72, 79-81] 
 
 
Summary 
The coronary venous system is a highly variable network of veins that drain 
deoxygenated blood from the myocardium. The system is made up of the greater cardiac 
system, which carries the majority of the deoxygentated blood to the right atrium, and the 
smaller cardiac system, which drains the blood directly into the heart chambers. The 
coronary veins are currently being used for several biomedical applications including but 
not limited to cardiac resynchronization therapy, ablation therapy, defibrillation, 
perfusion therapy, and annuloplasty. Knowledge of the details of coronary venous 
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anatomy is essential for optimal development and delivery of treatments that utilize this 
vasculature. 
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2. Visualization and Assessment of Human Coronary Venous 
Anatomy 
 
2.1. Coronary Venous Mapping on the Epicardial Surface [82] 
Julianne (Eggum) Spencer, Scott Skorupa, and Paul Iaizzo 
 
Preface 
As discussed in the previous section, there are various approaches to the 
assessment of the coronary venous system. In this study, we used a microscribe digitizer 
on the epicardial surface of perfusion fixed human hearts to evaluate the coronary veins. 
Scott Skorupa, a master’s student in the lab, initiated this work. Together, we gathered 
data and developed the method of quantifying the data. Ryan Lahm, a former graduate 
student, provided a Scoll code to obtain several of the measurements. Next, I oversaw the 
collection of venous measurements by a directed research undergraduate student, 
Konstantin Kravcheuko. In addition, I analyzed and presented pilot results at the Design 
of Medical Devices Conference in April of 2011 and the final results at the Transcatheter 
Cardiovascular Therapeutics Conference in November of 2011. 
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Introduction 
Understanding the anatomy of the human coronary venous system is important for 
the development and use of minimally invasive cardiac devices that utilize these vessels. 
This understanding is of particular interest for deploying cardiac resynchronization 
therapy (CRT) devices. In CRT, one typically places a lead within the cardiac veins 
overlaying the left ventricle to resynchronize cardiac rhythms. It is estimated that 10-20% 
of general heart failure patients in the United States may benefit from the placement of 
CRT [83]. 
Our lab is in the process of developing a unique detailed library of anatomical 
maps for a large sample of human cardiac venous systems that can be used by cardiac 
medical device designers to optimize the development process. From these obtained 
maps, one can measure various anatomical parameters that can be used as input design 
parameters. More specifically, these parameters are of value for optimizing device design 
for guidewires, leads, catheters, and lead extraction tools. 
 
Methods 
We have obtained maps for 18 perfusion fixed human hearts from the Visible 
Heart Library. These hearts were received through a collaboration with LifeSource (St. 
Paul, MN). The fresh specimens were perfusion fixed in their end-diastolic form. First, 
four of the great vessels (one connecting to each chamber of the heart) were cannulated 
and the remaining vessels were plugged. Then the hearts were placed in a chamber of 
formalin and the great vessel cannulas were connected to a second upper chamber of 
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formalin so that the heart was also filling with formalin. When formalin entered the aorta, 
it was forced through the coronary arteries and perfused through the tissue. A head 
pressure of approximately 50 mmHg was maintained by a pump to imitate the pressures 
in the heart. 
After at least 24 hours of perfusion fixing, each heart was considered fixed in its 
end-diastolic state. The coronary sinus of each heart in this study was cannulated with a 
venogram balloon catheter. A blue-dyed contrast media was injected through the catheter 
so that the veins were visible both on fluoroscopy and on the external epicardial surface 
displayed in Figure 2.1.1. 
Figure 2.1.1 External and fluoroscopic visualization of the coronary venous system  
External and fluoroscopy images a formalin perfusion-fixed human heart with blue-dyed 
contrast media injected into the cardiac venous system via a venogram balloon catheter 
within the coronary sinus. 
 
Next, a Microsribe Digitizer was used to obtain the relative three-dimensional 
coordinates of the visible cardiac veins. The three-dimensional coordinates for each heart 
were uploaded into Imageware software (Siemens, Munich, Germany). Figure 2.1.2 
presents an example of a dataset displayed in Imageware. Once the data points were 
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uploaded, curves were fit within one mm of the line that linearly connected each 
subsequent data point. One mm is the approximate error associated with the Microscribe 
method. 
Figure 2.1.2 Visualization of an Imageware dataset 
Left ventricular view of a cardiac vein dataset imported into Imageware before (a) and 
after (b) a smoothing algorithm. The vein on the far right is the middle cardiac vein 
(MCV) and the vein to the far left is the anterior interventricular vein (AIV). 
 
 2 Copyright © 2010 by ASME 
be of value for optimizing guidewire, lead, catheter, lead 
extraction tool, and/or mitral valve repair tool designs. 
METHOD 
For this study, to date we have obtained maps for 19 
profusion fixed human hearts from the Visible Heart Library.  
The CS of each heart was cannulated and injected with blue-
dyed contrast media so that the veins were visible both on 
fluoroscopy and on the external epicardial surface.  Figure 1 
shows an example of the venous structures of one heart visible 
through fluoroscopy and externally. 
 
   
Figure 1: External and fluoroscopy images a formalin fixed 
human heart with blue-dyed contrast media injected into the 
cardiac veins via a catheter within the coronary sinus. 
 
Next, a Microsribe 3DX Digitizer was used to obtain the 
relative three-dimensional coordinates of the visible cardiac 
veins (a tree-dimensional cloud array of digital values).  Figure 
2 displays the Microscribe 3Dx Digitizer being used to map the 
blue-dyed cardiac veins from one of the studied fixed human 
hearts. 
 
 
Figure 2: Utilization of the Microscribe 3Dx Digitizer on one of 
the sample specimens.  The cardiac veins have been injected 
with a blue dye. 
 
The three-dimensional coordinates for each heart were 
subsequently uploaded separately into Imageware software 
(Siemens, Plano TX).  An example of one of the datasets is 
displayed in Figure 3: 3(a) shows the raw data set imported into 
Imageware and 3(b) displays the set after an Imageware 
smoothing algorithm application. 
A script was written to calculate the diameter, arc length, 
and tortuousity of each vein. The branching angles were 
measured using manual Imageware commands. 
 
(a) 
 
 
(b) 
 
 
Figure 3: Lateral view of a cardiac vein dataset imported into 
Imageware before (a) and after (b) a smoothing algorithm.  The 
vein on the far right is the posterior interventricular vein (PIV) 
and the vein to the far left is the anterior interventricular vein 
(AIV). 
RESULTS 
We have begun to create a novel database of the 
anatomical cardiac vein parameters measured for 3 human 
hearts as displayed in Table 1(a) and (b).   Table 1(a) presents 
each major vein’s branching angle off the CS, arc length, and 
tortuousity. The branching angles are measured as the angle 
between the CS and the outline of the vein proximal to the CS.  
Relative tortuousities are measured by dividing the arc length 
of each vein by the shortest distance between the start and end 
of the vein. In Table 1(b), the major vein diameters are 
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Several anatomical parameters were ssessed for the coronary sinus nd its major 
tributaries: middle cardiac, inferior, inferior-lateral, lateral, antero-lateral, and anterior 
interventricular veins. The parameters assessed were the branching angle, arc length, 
tortuosity, and diameters for each vein. The branching angle was defined as the angle 
proximal to the coronary sinus ostium and was measured using manual Imageware 
commands. A Scoll script was written to calculate the remaining parameters. Arc length 
was defined to be the length of the vein. Toruosity was the arc length divided by the 
linear distance from the beginning to end of the vein. The percent of the arc length under 
2.0mm in diameter was also assessed. 
 
 28 
Results 
Table 2.1.1 and the graphs in Figure 2.1.3 summarize the resulting measurements 
for 18 human coronary venous systems. The middle cardiac and anterior interventricular 
veins had the longest arc length, highest tortuosity, and were the most prevalent veins. 
The inferior-lateral vein, which is the vein most commonly used for CRT, had the 
sharpest angle with the coronary sinus/great cardiac vein. The percentage of a vein with a 
diameter less than 2mm was largest in the antero-lateral vein, but was quite variable in all 
of the veins. 
Table 2.1.1 Coronary venous anatomical parameters 
Anatomical parameter means and standard deviations of the major coronary veins 
obtained from digital reconstructions using a microscribe. 
Vein Prevalence 
Branching 
Angle (°) 
mean +/- 
sd 
Arc Length 
(mm)       
mean +/- sd 
Tortuosity   
mean +/- 
sd 
% 
Diameter 
< 2mm 
Coronary 
Sinus 18 N/A 24 +/-  7 
1.04 +/- 
0.02 0.00 +/- 0 
Middle 
Cardiac Vein 18 125 +/- 29 115 +/- 22 
1.23 +/- 
0.13 6.2 +/- 7.7 
Inferior Vein of 
the Left 
Ventricle 
11 115 +/- 19 86 +/- 28 1.05 +/- 0.07 9.0 +/- 8.2 
Infero-lateral 
Vein 8 102 +/- 23 65 +/- 16 
1.14 +/- 
0.08 
12.7 +/- 
16.9  
Left lateral 
Vein 12 117 +/- 32 78 +/- 35 
1.15 +/- 
0.10 
26.8 +/- 
32.8 
Antero-lateral 
Vein 7 122 +/- 31 48 +/- 22 
1.11 +/- 
0.03 
31.3 +/- 
28.7  
Anterior 
Interventricular 
Vein 
15 120 +/- 24 113 +/- 27 1.29 +/- 0.21 
10.34 +/- 
13.7 
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Figure 2.1.3 Bar charts of coronary venous parameters 
Coronary venous measurements for (a) arc length, (b) tortuosity, (c) branching angle, and 
(d) percent of the vein with a diameter less than 2mm 
(a)  
 
(b)  
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(c)  
 
     (d)  
 
 
Discussion 
We found that some of our results varied with the literature (Table 2.1.1). For 
example, the arc lengths we measured were overall longer than those presented in the 
literature. This may be due to our method of fixation. We perfusion fix human hearts so 
that they are fixed in their end diastolic state. The literature studies involved 
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measurements on patients or cadavers whose hearts were most likely not in their end 
diastolic form. The branching angles we measured were also larger than those found in 
the literature overall. However, the branching angle standard deviations calculated in 
both our study and the literature were relatively high. It may be that the branching angle 
of each vein varies significantly between hearts. On the other hand, we found similar 
patterns when comparing anatomical parameters between veins. For example, the longest 
coronary veins were the middle cardiac vein and anterior interventricular vein in our 
study and in the literature. There were also high prevalence percentages for the coronary 
sinus, middle cardiac vein, and anterior interventricular vein in this study and in the 
literature. 
One potential limitation of creating this study’s database is the varied amount of 
adipose tissue that may exist on the epicardial surface of the perfusion fixed human 
hearts. This may limit our abilities to precisely digitize all venous anatomies. For 
example, the majority of the anterior interventricular vein of three of the 18 hearts was 
covered with adipose tissue and was not able to be traced with the microscribe. As a 
result, the measurements were not obtained for these three anterior interventricular veins 
even though it was believed that these hearts contained this vein. Another limitation of 
the study was that the veins within the three-dimensional models were two-dimensional. 
The models demonstrated the width of each vein on the epicardial surface, but the depth 
of the vein could not be assessed. 
In the future, to overcome these limitations and as a means to validate this 
database, we will obtain additional cardiac maps from the human hearts used in this study 
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with computed tomography (CT) and MIMICs reconstruction software. A more detailed 
analysis of these parameters is presented in a subsequent section of this thesis. 
Despite these limitations, the development of a database of cardiac venous 
anatomy will be useful for the design of medical devices that utilize these vessels. The 
data collected in this study can be used as inputs into the design of left-sided leads and 
their delivery devices. 
 
.  
 
 33 
2.2. Coronary Venous Mapping with Contrast-Computed 
Tomography 
Julianne Spencer, Allison Larson, Rachel Drake, Paul Iaizzo 
 
Preface 
 The motivation for this research was brought about from the previous study, in 
which we employed a microscribe to map the coronary veins. As previously described, 
the microscribe method had two apparent limitations: (1) the method did not account for 
adipose tissue covering the veins and (2) the generated maps were two-dimensional and 
did not reflect the volume of the venous system. To overcome these limitations, we 
developed a method to map the coronary venous system with contrast-computed 
tomography. The methods involved in this study have been published as a video 
manuscript in The Journal of Visualized Experiments. The preliminary results of this 
study were presented at the Heart Rhythm Conference in 2012. This chapter is presented 
as the paper that has been accepted for publication at Heart Rhythm Journal. 
 Computed tomography is a commonly used imaging modality in the medical field 
for diagnostics. The CT scanner has a frame with X-ray sources and detectors across 
from one another. The frame is rotated while the source emits X-rays. The detector 
detects the extent that the X-ray has been attenuated. Each X-ray is backwards 
reconstructed by specialized software and a slice is generated for each 360-degree 
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rotation. We chose to use CT imaging because it is accurate, fast, and easily accessible at 
Fairview Hospital (Minneapolis, MN). 
My responsibilities in this project included obtaining CT scans, method and 
analysis development, model generation, and measurement collection. Allison Larson and 
Rachel Drake assisted in all of these areas. Emily Fitch contributed to the method 
development and was a co-author in the Journal of Visualized Experiments publication. 
Dionna Gamble, Cassandra Sundaram, and Katia Torres assisted in data collection. 
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Introduction	  
Understanding the coronary venous system is critical for the development and 
deployment of therapies and devices that utilize these vessels. Current devices include 
cardiac resynchronization therapy [84], coronary sinus ablation [18, 20], coronary artery 
bypass [13], mitral valve annuloplasty devices [25], defibrillation [85], and cell therapy 
[86, 87]. 
Cardiac resynchronization therapy (CRT) is currently one of the most common 
clinical applications that require access to the coronary venous system. During CRT, a 
pacing lead is placed in a coronary vein to pace the left ventricle, ideally at the latest site 
of activation to improved delayed conduction [88-93]. For the majority of patients, this 
delay occurs on the inferolateral side of the heart [29]. Several clinical trials have 
demonstrated that CRT is an effective therapy for moderate to severe heart failure [94-
97]. However, 30% of patients do not respond to the treatment. One of the predictors for 
nonresponders is suboptimal lead placement[98]. A better understanding of the coronary 
venous anatomy is essential for improving suboptimal lead placements. 
The coronary veins are referred to by several different nomenclatures in the 
literature. We chose to use attitudinally correct nomenclature consistent with our previous 
publications[1, 99]. In this study, we further classified the lateral veins into three 
subgroups: (1) inferolateral veins, (2) left lateral veins, and (3) anterolateral veins. The 
anatomy of the inferolateral veins is of particular relevance to the development of CRT 
delivery devices[29]. 
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In this study, images obtained from computed tomography scans (CTs) are used 
to construct three-dimensional models of the coronary venous system. These models are 
used to evaluate the venous anatomy in order to provide inputs for the design of devices 
deployed into these vessels. In addition, the results this study can provide 
electrophysiologists with a further understanding of the range of venous anatomy that can 
be expected during procedures that require access to the veins. Specifically, the study 
aims to identify the major coronary veins on the inferolateral side of the heart for the 
application of CRT. In addition, the information will be used to evaluate anatomical 
differences and their relation to varying diseased states. The conditions of interest for this 
study include hypertension, atrial fibrillation, and coronary artery disease. Specimens 
from patients with a history of these disorders were evaluated. 
 
Methods [100] 
We assessed the coronary venous system of 121 freshly obtained human hearts. 
These specimens were obtained through LifeSource Inc. (Organ and Tissue Donation, St. 
Paul, MN) or The University of Minnesota Anatomy Bequest Program (Minneapolis, 
MN). The hearts were perfusion fixed using 10% formalin. The superior vena cava, 
pulmonary trunk, one pulmonary vein, and the aorta of each specimen were cannulated 
and connected to an upper-container filled with formalin. The specimens were submerged 
in formalin in a lower container while formalin was continuously pumped to the upper 
chamber to maintain a pressure head of 40-50 mmHg. This method fixes the specimens in 
their approximate end diastolic shape [81, 100]. 
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Detailed medical histories were available for 114/121 of the specimens and are 
summarized in Table 2.2.1. We compared anatomical parameters between four subgroups 
based on the reported cardiac history: 1) no history of cardiac disease, 2) heart failure 3) 
hypertension, 4) atrial fibrillation, and 5) coronary artery disease. Table 2.2.2 presents the 
mean and standard deviation of the patient weights and ages for the study population and 
each subgroup. 
Table 2.2.1 Summary of the study population’s medical history 
Medical History Sample Size 
Total Study Population 121 
Healthy 34 
Heart Failure 11 
Hypertension 45 
Atrial Fibrillation 14 
Coronary Artery 
Disease 11 
Other Cardiac History 29 
No Data Available 7 
 
Table 2.2.2 Mean and standard deviation of the patient weight and age for the study 
population and subgroups 
 Patient Weight (kg) Age 
All Hearts n = 121 79.9 ± 19.8 58.0 ± 15.9 
Healthy n = 34 77.3 ± 21.3 52.6 ± 18.3 
Heart Failure n =11 81.0 ± 21.1 66.6 ± 16.7 
Hypertension n = 45 82.3 ± 19.4 63.1 ± 12.3 
Atrial Fibrillation n = 14 77.3 ± 22.5 72.1 ± 12.1 
Coronary Artery Disease n = 11 85.0 ± 21.6 62.0 ± 11.8 
 
Contrast-CT 
  The specimens were scanned using a 64 multi-detector computed tomography 
scanner (Sensation 64, Siemens, Munich, Germany) at the University of Minnesota 
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Fairview Imaging Services. To prepare for the CT scans, the coronary sinus of each 
specimen was cannulated with a venogram balloon catheter and placed the specimen in 
its anatomically correct position within the scanner. Contrast was injected into the venous 
system at five milliliters per second for eight seconds and the CT scan was obtained. 
Following the contrast injection, the catheter and venous system were flushed with saline 
to remove the remaining contrast. The resulting scans provided 512 x 512 resolution 
images with 0.6mm slice thickness [100]. 
 
Model Generation and Anatomical Assessment 
The CT scans were uploaded into Mimics software (Materialize, Leuven, 
Belgium) and the coronary venous system of each specimen was reconstructed into a 
three-dimensional model as displayed in Figure 2.2.1. Centerlines were generated for the 
resulting three-dimensional model. The prevalence of the major veins as well as the 
prevalence of any major vein on the basal inferolateral side was recorded. 
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Figure 2.2.1 A labeled left lateral view of a reconstructed model of the coronary 
venous system 
 
 
Anatomical parameters were then assessed for each primary vein over 20mm long 
using Mimics and 3-Matic Software (Materialise). Veins less than 20mm long were 
considered not clinically relevant and therefore were not assessed. The arc length of each 
major vein was measured using the generated centerlines from the start to the end of the 
vein. Tortuosity was assessed as the ratio of the arc length to the linear distance from the 
start to the end of the vein. The proximal branching angle to the coronary sinus was 
determined as well as the distance from each vein’s ostium to the coronary sinus ostium. 
The long and short axis of each vein’s ostium was measured by reslicing the CT images 
so that the ostium was in plane as displayed in Figure 2.2.2. For the inferolateral veins or 
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veins with branches on the inferolateral wall, the CT images were resliced along the 
centerline of the vein. The minimum venous diameter was measured 40mm from the 
venous ostium. It was recorded if this diameter was less than 1.6mm, which indicated the 
vessel was too small to implant a 5F lead. The number of secondary branches for each 
primary vein was recorded as well. 
Figure 2.2.2 Ostial measurements for a left lateral vein 
The measurements were taken on a contrast-CT image resliced normal to the coronary 
vein. 
 
 
Statistical Analysis 
 Anatomical parameters are presented as mean values with their standard 
deviations. For each parameter, normal and nonparametric tolerance intervals were 
calculated for 90% of the population with 95% confidence using Minitab (State College, 
PA). This generates a range that includes 90% of the population with 95% certainty. In 
other words, it provides the upper and lower extremes for each parameter in the 
population. Anderson-Darling statistical analyses were performed for each dataset to 
determine if the data distributions were normal or nonparametric. Datasets resulting in a 
p-value less than 0.05 were considered nonparametric. Wilcoxon rank-sum tests were 
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performed to compare anatomies between specimens with no history of cardiac disease 
and specimens with a history of (1) heart failure, (2) hypertension, (3) atrial fibrillation, 
and (4) coronary artery disease. 
 
Results 
 Table 2.2.3 summarizes the prevalence for each major vein.  Only 12%  (14 of 
121) of the specimens had a visible small cardiac vein over 20mm in arc length. All 
specimens had one middle cardiac vein and one anterior interventricular vein.  The 
specimens varied in how many major inferior and lateral veins were present. 
Table 2.2.3 Prevalence of the major coronary veins in 121 human hearts 
 
 
 
Vein 
 
Total 
Prevalence 
from 121 
Specimens 
# 
Specimens 
with None 
of the 
Specified 
Vein 
# of 
Specimens 
with 1 of 
the 
Specified 
Vein 
# of 
Specimens 
with More 
than 1 of the 
Specified 
Vein 
Small Cardiac Vein 14 107 14 0 
Middle Cardiac Vein 121 0 121 0 
Inferior Vein 135 28 56 37 
Inferolateral Vein 65 64 49 8 
Left Lateral Vein 153 16 64 41 
Anterolateral Vein 70 67 40 14 
Anterior 
Interventricular Vein 
121 0 121 0 
 
 The inferolateral region is of particular interest since it is commonly paced during 
CRT. Figure 2.2.3 illustrates the prevalence of veins that lay over this region. Fifty-two 
percent (63 of 121) of the specimens did not have a primary vein branching off of the 
coronary sinus on the inferolateral side. However, 79% of the specimens without an 
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inferolateral vein (41% overall) had a venous branch from an inferior or lateral vein that 
coursed through this area. The remaining 11% of the hearts in the study population were 
without a major vein overlaying the inferolateral region of the heart. In addition, the 
diameters of 20% (18% overall) of the vessels that coursed over the inferior lateral side 
were too small to place a 5F lead. 
Figure 2.2.3 The prevalence of major coronary veins in the inferolateral region of 
the heart 
Boxes in red indicate that cardiac resynchronization therapy would not be able to be 
applied to an inferolateral region of the heart. Blue boxes indicate that a pacing lead 
could be placed in an inferolateral vein. Cyan boxes indicate that a pacing lead could be 
placed in a branch of a left lateral or inferior vein that courses over the inferolateral 
region of the heart. 
 
 
Table 2.2.4 and Figures 2.2.4a-g summarize the anatomical parameters assessed 
for 121 human coronary venous systems. The anterior interventricular vein had a 
noticeably larger branching angle (164.8°) on average than the other primary coronary 
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veins (next largest at 103.0°). The middle cardiac veins and anterior interventricular veins 
were typically the longest (129.7mm and 125.5mm respectively) and most tortuous veins 
(1.37 and 1.35). These two interventricular veins also had the most branches (6.8 and 9.9) 
and largest ostial long (5.7mm and 5.4mm) and short (4.1mm and 4.5mm) diameters on 
average. There was considerable variation within the study population for all of the 
parameters. However, the number of branches per major coronary vein varied the most 
from specimen to specimen. There was also a substantial amount of variation in the 
calculated tolerance intervals for the overall population. Table 2.2.5 displays the range of 
parameters for 90% of the population with 95% confidence. 
Table 2.2.4 Coronary venous anatomical parameters 
Mean and standard deviations of coronary venous anatomical parameters assessed for 
121 human hearts 
Vein 
Distance to 
the Coronary 
Sinus 
Ostium 
(mm) 
Branching 
Angle (°) 
Arc Length 
(mm) Tortuosity 
Number 
of 
Branches 
Ostial 
Short 
Axis 
Diameter 
(mm) 
Ostial 
Long 
Axis 
Diameter 
(mm) 
Small Cardiac 
Vein (SCV) 
n=14 
18.5 ± 11.2 100.2 ± 21.8 33.0 ± 9.2 1.15 ± 0.06 0.2 ± 0.4 2.9 ± 1.4 4.5 ± 2.1 
Middle Cardiac 
Vein (MCV) 
n=121 
9.0 ± 5.4 87.8 ± 22.1 129.7 ± 23.4  1.37 ± 0.22 6.8 ± 4.4 4.1 ± 1.5 5.7 ± 1.9 
Inferior Vein 
(IV) n=135 21.3 ± 10.2 95.4 ± 19.4 79.4 ± 42.6 1.22 ± 0.17 4.0 ± 4.4 2.7 ± 0.9 4.0 ± 1.5 
Inferolateral 
Vein (ILV) 
n=60 
42.4 ± 12.9 93.5 ± 17.0 67.2 ± 34.1 1.27 ± 0.39 3.7 ± 4.3 3.1 ± 1.3 4.0 ± 1.3 
Left Lateral 
Vein (LLV) 
n=153 
66.7 ± 12.9 103.0 ± 24.8 76.4 ± 35.6 1.24 ± 0.15 5.0 ± 4.6 3.3 ± 1.3 4.2 ± 1.5 
Anterolateral 
Vein (ALV) 
n=70 
88.0 ± 17.8 95.7 ± 15.4 46.3 ± 23.2 1.18 ± 0.11 1.5 ± 2.3 2.4 ± 0.8 3.1 ± 1.1 
Anterior 
Interventricular 
Vein (AIV) 
n=121 
101.0 ± 15.0 164.8 ± 22.1 125.5 ± 31.3 1.35 ± 0.17 9.9 ± 5.6 4.5 ± 1.1 5.4 ± 1.3 
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Figure 2.2.4 Bar charts of Coronary Venous Measurements 
Mean and standard deviations of (a) distance to the coronary sinus ostium, (b) branching 
angle, (c) arc length, (d) tortuosity, (e) number of branches, (f) ostial short axis diameter, 
and (g) ostial long axis diameter 
(a) 
 
 
(b) 
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(c) 
 
 
(d) 
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(e) 
 
 
(f) 
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(g) 
 
 
Table 2.2.5 90% tolerance interval for the population with 95% confidence for each 
of the anatomical parameters measured in the study 
An asterisk* indicates that the data has a nonparametric distribution. Data without an 
asterisk indicate a normal distribution. 
 Distance to 
the 
Coronary 
Sinus (mm) 
Branching 
Angle (°) 
Arc 
Length 
(mm) 
Tortuosity Number 
of 
Branches 
Ostial 
Short Axis 
Diameter 
(mm) 
Ostial 
Long Axis 
Diameter 
(mm) 
Small Cardiac 
Vein 
0 - 
47.5 
34.9 –  
165.5 
9.7 - 
56.3 
1.00 –  
1.3 
0 –  
1* 
0 –  
6.4 
0 –  
9.8 
Middle Cardiac 
Vein 
0 –  
22.2* 
21.6 –  
167.7* 
86.3 - 
173.2 
1.1 –  
1.9* 
1 –  
18* 
2.0 –  
7.7* 
2.2 –  
9.2 
Inferior Vein 5.3 –  
44.9* 
66.4 –  
154.2* 
22.5 - 
173.9* 
1.0 –  
1.6* 
0 – 
16* 
1.3 –  
5.0* 
1.9 –  
7.8* 
Inferolateral 
Vein 
17.0 –  
67.7 
56.5 –  
175.2* 
22.8 - 
139.1* 
1.0 –  
4.0* 
0 – 
20* 
1.6 –  
7.8* 
2.3 –  
8.0* 
Left Lateral 
Vein 
43.1 –  
90.3 
76.3 –  
172.1* 
20.6 - 
140.8* 
1.1 –  
1.6* 
0 – 
16* 
1.4 –  
6.3* 
2.1 –  
7.4* 
Anterolateral 
Vein 
53.8 –  
122.3 
58.3 –  
143.8* 
11.3 - 
110.4* 
1.0 –  
1.5* 
0 –  
9* 
0.8 – 
 3.9 
1.6 – 
 5.8* 
Anterior 
Interventricular 
Vein 
73.9 - 
129.1* 
83.6 –  
178.1* 
67.6 - 
183.3 
1.1 –  
1.7* 
2 – 
25* 
2.4 –  
6.5 
3.0 –  
7.8 
 
Wilcoxon rank tests were performed to compare anatomies between specimens 
with no history of cardiac disease and specimens with a history of: 1) heart failure, 2) 
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hypertension, 3) atrial fibrillation, and 4) coronary artery disease. The patient weights 
were not found to be significantly different. The patient ages were significantly older for 
the specimens with a history of heart failure (p=0.049), atrial fibrillation (p=0.001), and 
hypertension (p = 0.038) compared with specimens with no history of cardiac disease. In 
terms of coronary venous parameters, there were only five statistically significant 
(p<0.05) differences found between specimens with no history of cardiac disease and the 
diseased subpopulations, which included: 1 & 2) larger anterolateral ostial short and long 
axis diameters for hearts with a history of heart failure, 3) smaller inferolateral ostial long 
axis diameters for hearts with coronary artery disease (p=0.013), 4) larger left lateral 
venous branching angle for hearts with hypertension (p=0.027), and 5) larger 
anterolateral ostial short axis diameter for hearts with hypertension (p=0.029). No 
consistent significant differences were found across any vein or anatomical parameter for 
the specimens in this study. The anatomical parameters for specimens with a history of 
heart failure are of clinical relevance to cardiac resynchronization therapy. These 
parameters and their associated p-values compared to specimens with no history of 
cardiac disease and to the total sample are presented in Appendix B.  
 
Discussion 
 In this present investigation, the anatomy of the coronary venous systems of 121 
human perfusion-fixed hearts was assessed using contrast-computed tomography. This 
technique allowed for the generation of three-dimensional models and subsequent 
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analysis to be incorporated into the development of medical devices that require access to 
the coronary veins. 
We assessed the prevalence of the major coronary veins for 121 specimens. The 
small cardiac vein was only visualized in 12% (14/121) of the specimens, which is most 
likely due to its small size. There is also the possibility that the contrast was injected 
distal to the ostium of small cardiac vein. To investigate this potential limitation, we 
attempted to identify the small cardiac vein with direct visualization via an endoscope. 
We were able to identify the ostium of the small cardiac vein in 11% of the specimens 
that did not show a small cardiac vein in their reconstructed models. This suggests that 
the majority of small cardiac veins were too small to visualize either directly or on CT. 
There was no variation between specimens regarding the prevalence of the middle 
cardiac vein and the anterior interventricular veins; all specimens contained one of each. 
There was apparent variation in the prevalence of the inferior and lateral veins amongst 
this study population. Hearts containing a large inferior vein typically had smaller or 
absent lateral veins (and vice versa). 
The prevalence of coronary veins on the inferolateral side is of particular interest 
for cardiac resynchronization therapy. This region of the heart is regarded as the optimal 
location for left-sided lead placement in the majority of CRT patients [29]. Twenty-nine 
percent of the specimens either did not have a major venous branch on the inferolateral 
side or had veins in this region with diameters less than 1.6mm. A lead implanted in a 
suboptimal position due to these limitations in anatomy could be a factor in the 30% non-
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responder rate[98]. An endocardial or subxyphoid epicardial approach for lead placement 
may be more appropriate for this 11% to achieve an optimal pacing position. 
 Table 2.2.4 provides anatomical parameters that can serve as inputs into the 
design of medical devices that utilize the coronary venous system. The distance to the 
coronary sinus ostium increased from the proximal primary veins to the more distal veins 
as expected. The small cardiac vein, on average, had longer distances to the coronary 
sinus ostium compared to the middle cardiac vein because, in several hearts, the small 
cardiac vein drained directly into the middle cardiac vein instead of the coronary sinus. 
Overall the branching angles measured for each vein varied considerably across the 
sample. The inferolateral veins, for example, produced a 90% tolerance interval between 
56.5° and 175.2°, which implies that a lead delivery catheter will need to accommodate 
venous branching angles within this range. The branching angle of the anterior 
interventricular vein was much larger (approximately 160°) than the other veins on 
average. This suggests that for future interventions, such as cell or drug delivery, the 
anterior interventricular vein could be considered to be anatomically easier to access 
since a broader angle for access would be required. The middle cardiac vein and anterior 
interventricular vein were the largest veins in terms of both arc length and ostial 
diameter, which would allow for more space during device and/or therapy delivery. This 
was also expected since these veins are known to be largely responsible for the draining 
of the left and right ventricular free walls as well as the interventricular septum [1]. These 
two veins were also found to be the most tortuous with the largest amount of secondary 
venous branches. 
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There was a high variation in the studied anatomical parameters both across the 
study population reflected in the large standard deviations and in the overall population 
reflected by the large tolerance intervals. This observation stresses the clinical importance 
of understanding a patient’s individual anatomy before performing a planned 
intervention. Today, imaging data can be obtained via preoperative computed 
tomography (CT), biplane fluoroscopy, or magnetic resonance. 
 Comparisons between healthy specimens and specimens with a history of cardiac 
disease resulted in no consistent significant differences between groups. This suggests 
that coronary venous anatomy is similar across disease states, including heart failure, 
which is the target population for cardiac resynchronization therapy. Nevertheless, it 
should be considered that some of the subgroups were composed of a limited sample size. 
On the other hand, even with larger group sizes, the clinical relevance of such anatomical 
variations may be of minor clinical importance. Therefore, this is one of the rationales we 
used to summarize the data together as a whole population. 
In previous studies, the coronary venous system has been assessed with cadavers 
[63, 64, 66, 101], magnetic resonance imaging[62, 80, 102], and computed tomography 
[31, 58-61, 103]. However to the authors’ knowledge, this is the first study to use 
contrast-CT on perfusion-fixed human hearts. This method allowed for specimens to be 
rescanned if needed without the radiation and contrast hazards to a live patient. This is 
also the first report, to our knowledge, that incorporated all of the presented parameters as 
well as describe in detail the prevalence of veins on the inferolateral side of the heart. 
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 There are a couple potential limitations associated with our study. There is a 
possibility that the contrast injection did not completely fill the coronary veins within a 
given specimen. Another limitation is that we were only able to generate models of the 
veins when the hearts were preserved in their end-diastolic state and not throughout the 
cardiac cycle. Hence, the parameters presented here should be considered the maximal 
vessel parameters across the cardiac cycle. Also as noted above, some of the subgroups of 
various cardiac disease states were fairly small (11 specimens in the smallest group) due 
to availability. The future, additional comparisons should be performed with larger 
subgroups. As our laboratory’s library of human hearts grows, we will continue to 
develop this novel database. This will allow for the analysis of larger subgroups based on 
cardiac disease state. One added benefit of the method used in this study is that the 
specimens are retained for additional scanning or analyses. 
 The novel study approach of this unique library of obtained contrast-CT images of 
perfusion-fixed hearts will serve as an important resource for both medical device 
designers and those delivering such therapies. 
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3. Visualization and Assessment of Surrounding Anatomy 
Relative to the Coronary Venous System 
 
3.1. Left Phrenic Nerve Anatomy Relative to the Coronary Venous 
System: Implications for Phrenic Nerve Stimulation during Cardiac 
Resynchronization Therapy 
Julianne Spencer, Ryan Goff, and Paul Iaizzo 
 
Preface 
 The left and right phrenic nerves run along the margin of the heart and stimulate 
the diaphragm. Due to their close proximity to the heart, the phrenic nerves can be 
negatively affected by cardiac interventions. During cardiac resynchronization therapy, 
the phrenic nerve can be stimulated by the left-sided lead [30]. In addition, there have 
been reports of the phrenic nerve damage during pulmonary vein isolation ablations 
[104]. However, there is little information available in the literature regarding phrenic 
nerve anatomy relative to cardiac structures. The purpose of this study is to better 
understand the left phrenic nerve anatomy relative to the major coronary veins.  The 
method we used is similar to that in Chapter 2.2 with the addition of highlighting the 
phrenic nerve by gluing a radiopaque wire to the nerve. The heart-lung blocks presented 
here were also used in a study led by Ryan Goff to assess the phrenic nerve anatomy in 
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relation to the pulmonary veins to investigate implications of phrenic nerve damage from 
cardiac ablations. 
 Ryan and I harvested the majority of the heart-lung blocks from the University of 
Minnesota’s Anatomy Bequest Program. We then perfusion-fixed the heart-lung blocks. 
Once the specimens were fixed, I was responsible for the contrast-CT scans, the post-
processing protocol, and measurement collection and analysis. The preliminary results of 
this study were presented at the Transcatheter Cardiovascular Therapeutics (TCT) 
Conference in 2013. The poster was chosen as one of the Top 50 Posters at TCT 2013. 
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Introduction	  
A current challenge associated with left ventricular implantation procedures is 
undesirable phrenic nerve stimulation. Left ventricular leads are typically placed within a 
coronary vein on the epicardial surface of the left ventricle. Phrenic nerve stimulation at 
implantation or follow up has been reported to occur in over a third of patients[30]. 
Within the thorax, the left phrenic nerve typically courses anterior to the hilum of 
the left lung and curves between the pericardium and mediastinal pleura around the left 
atrial appendage and the lateral side of the left ventricle and then terminates at the 
diaphragm[105]. However, there is limited detailed information available regarding the 
anatomy of the left phrenic nerve in relation to the coronary veins. At least four studies 
have reported the prevalence of the phrenic nerve overlapping different regions of the 
heart using cadaveric specimens [101, 106, 107] and patient computed tomography [108]. 
To the authors’ knowledge, one study has reported quantitative measurements that 
characterized the relationship between the left phrenic nerve and the coronary venous 
system. Sanchez-Quintana et al found that the left phrenic coursed on average a minimum 
of 1.4mm from the great cardiac vein and 3.5mm from the left obtuse marginal vein 
[107]. 
The major coronary veins have varying nomenclatures evident in the literature. 
We will refer to the veins with attitudinally correct nomenclature consistent with our 
previous publications [109]. Figure 1 indicates the coronary venous nomenclature 
referred to in this study. 
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The purpose of this study is to further quantify the extent which the left phrenic 
nerve overlays the coronary veins in order to better understand the potential for phrenic 
nerve stimulation during cardiac resynchronization therapy. 
 
Methods 
Specimen Preparation 
Fifteen perfusion-fixed human heart-lung blocks were modeled in this study. The heart-
lung blocks were obtained from the University of Minnesota’s Anatomy Bequest 
Program. The mean age of the patients was 81.1 ± 10.8 years old. The heart-lung blocks 
were perfusion fixed as previously described, but with the lungs, to maintain the heart’s 
end diastolic state [110, 111]. In end-diastole, the heart is maximally expanded and the 
coronary veins are considered here to be the closest to the phrenic nerve. Therefore, the 
end-diastolic stage in the cardiac cycle should generate the highest risk of phrenic nerve 
stimulation. 
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Contrast-Computed Tomography 
After fixation, the heart-lung blocks were prepared for computed tomography 
(CT) scanning. A small wire was glued to the left phrenic nerve so that it would be 
detected on CT. Each heart-lung block was placed in the scanner in its supine anatomical 
position. Contrast was injected into the coronary venous system at 5ml/s through a 
venogram balloon catheter placed in the coronary sinus as previously described [100]. 
The CT scan was obtained using a Siemens 64 multi-detector scanner (Munich, 
Germany). 
 
Model Generation 
 The CT dicom files were uploaded into Mimics Software (Materialise, Leuven, 
Belgium). Three-dimensional reconstructions of the left phrenic nerve and coronary veins 
were generated as displayed in Figure 3.1.1. Centerlines were generated for the 
reconstructions. The locations of where the phrenic nerve overlapped the coronary veins 
were recorded. The distance between the centerlines of the phrenic nerve and coronary 
venous system was calculated for each of these intersections using Matlab Software 
(Mathworks, Natick, Massachusetts). The distance between the centerlines was then 
subtracted by the venous radius, measured in Mimics on a CT slice perpendicular to the 
venous centerline, and the radius of the wire placed on the nerve, 0.5mm, to calculate the 
distance between the coronary vein and phrenic nerve. 
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Figure 3.1.1 The phrenic nerve and coronary venous reconstructions for one study 
specimen in a left lateral view 
 
The angle proximal to the coronary sinus ostium between the phrenic nerve and 
coronary vein at each intersection was measured using 3-matic Software (Materialise, 
Leuven, Belgium). The venous distance to the atrioventicular groove and coronary sinus 
was also assessed with Mimics and 3-matic software. Figure 3.1.2 illustrates the 
measurements taken on the three-dimensional models. 
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Figure 3.1.2 Visualization of the assessed anatomical parameters for each location 
where the phrenic nerve overlaps a major coronary vein 
(A) The shortest distance between the nerve and the vein, (B) the distance to the coronary 
sinus, (C) the distance to the coronary sinus ostium, and (D) the angle between the nerve 
and the vein proximal to the CS ostium. 
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Statistical Analysis 
 Assessed parameters are presented as mean values ± their standard deviations. 
Boxplots of the minimum and 4 quartiles of each parameter are also presented. 
 
Results 
Table 3.1.1 displays the mean and standard deviations of the anatomical 
parameters assessed. Note that in several of the specimens, the nerve overlapped some of 
the veins in multiple locations. The phrenic nerve most often overlapped the anterior 
interventricular vein (73.3%). The nerve overlapped the left marginal vein, which are the 
veins typically used in left-sided pacing, in 53.3% of the specimens. The coronary sinus 
(20.0%) and middle cardiac vein (26.7%) were overlapped the least. 
 
Table 3.1.1 Mean ±	 standard deviations of anatomical parameters for each major 
coronary vein of 15 perfusion-fixed humans hearts. 
 
 
Figure 3.1.3 displays the associated boxplots for the dataset to provide 
visualization of the anatomical variation between specimens. The phrenic nerve coursed 
the closest to the middle cardiac vein and left marginal veins. The nerve typically coursed 
over the basal region of the anterior interventricular vein, the mid region of the left 
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marginal veins, and the apical region of the inferior and middle cardiac veins, which 
resulted in the distance to the coronary sinus ostium to be fairly consistent across the 
coronary sinus tributaries. There was a large variation associated with the angle between 
the nerve and the veins, but the average angle was also found to be fairly consistent 
across the major coronary sinus tributaries. 
Figure 3.1.3 Boxplots of various anatomical parameters for each location where the 
nerve overlaps a coronary vein 
(A) The shortest distance between the nerve and vein, (B) distance from the intersection 
location to the coronary sinus, (C) distances from the intersection location to the coronary 
sinus ostium, and (D) the angle between the nerve and vein proximal to the coronary 
sinus ostium. The minimum for each venous parameter is marked in blue, the first 
quartile is marked in red, the median is marked in green, the third quartile is marked in 
purple, and the maximum is marked in cyan. 
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Discussion 
The characterization of the phrenic nerve’s spatial relationship to the coronary venous 
system has been assessed here in clinically relevant detail. To the authors’ knowledge, 
the present study is the first to report the distance to the coronary sinus, the distance to 
the coronary sinus ostium, and the angle between the phrenic nerve and major coronary 
vein at each intersection as well as the first study to employ contrast-CT imaging of 
perfusion-fixed hearts to assess these parameters. 
 We found that the average shortest distance between the nerve and left marginal 
vein was 3.4mm, which is consistent with Sanchez-Quintana et al previous assessment 
(3.5mm) [107]. However, we did find larger distances on average between the coronary 
sinus (7.3mm) and anterior interventricular vein (6.3mm) relative to the Sanchez 
Quintana et al study (1.4mm), where they referred to these veins as the great cardiac vein. 
Our study showed that the nerve generally coursed closer to the coronary veins on the 
lateral and inferior side of the heart relative to the anterior side. 
 The distance to the coronary sinus varied between the major veins, but the 
distance to the coronary sinus ostium showed much less variation. Interestingly, the 
distance a catheter would be required to travel through the coronary veins to reach the 
phrenic nerve (90.8mm-129.4mm on average) was fairly consistent across the veins. We 
found that the nerve was located on the basal region of the anterior side of the heart and 
coursed toward the apex on the inferior side of the heart. 
 As mentioned in the results, the average angle between the phrenic nerve and 
major coronary veins was also fairly consistent, which suggests the nerve courses down 
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the heart while overlapping the major veins at a relatively constant angle. However, as 
displayed in Figure 3.1.3(D), there was a large variation in quantity of this intersecting 
angle between specimens. 
There were some limitations involved with this study. The sample size was 
relatively small at 15 heart-lung block specimens. In addition, the measurements are 
static and do not take into account the movements generated in the cardiac or respiratory 
cycle. In order to achieve static measurements in which the phrenic nerve was closest to 
the coronary veins, we fixed the heart in its end-diastolic state and sealed the lungs during 
fixation. 
 
Conclusion 
The purpose of this study was to characterize the phrenic nerve anatomy relative 
to the coronary venous system. Understanding of the proximity of the phrenic nerve to a 
left-sided pacing lead position is important for physicians and device developers to avoid 
unwanted phrenic nerve stimulation. We found that the phrenic nerve overlaps a left 
marginal vein in over half of the specimens in this sample. We will continue to expand 
this novel anatomical database to provide further insights for phrenic nerve stimulation 
reduction during left-sided pacing. 
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3.2. The Anatomical Relationship Between the Coronary Artery and 
Coronary Venous Systems 
Julianne H. Spencer, Casandra Sundaram, and Paul A. Iaizzo 
 
Preface	  
 The coronary arteries are essential for supplying the myocardium with oxygen 
and nutrients. Therefore, it is imperative that the arteries are not adversely affected by 
interventions in the nearby coronary veins. The objective of this study is to understand 
where the coronary arteries course the closest to the coronary veins, how big these 
arteries are, and the extent that their anatomical relationship varies between patients. 
This study is of particular interest in the development of active-fix left-sided 
pacing leads. Active fix leads have a helix that can screw into the vein wall lumen to 
prevent dislodgement. The motivation of this study is to locate what areas on the heart 
have the highest risk of the lead’s helix perforating through a nearby artery. We are also 
investigating the size of the arteries that course near the coronary venous in order to 
gauge if a perforation would cause an adverse effect. This study also has implications for 
coronary artery therapies delivered through the coronary veins. 
For this project, I led the method and analysis development, obtained the contrast-
CTs, and contributed to the collection of measurements. Cassandra Sundaram assisted me 
in all of these areas. In addition, she was responsible for summarizing the existing 
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literature and three-dimensional model generation. The preliminary methods and results 
for this study were presented at the Heart Rhythm Conference in 2012. 
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Introduction 
 
 Three-dimensional computer modeling and analysis of the human coronary 
arterial and venous systems are necessary for the development of devices and application 
of therapies that utilize these vessels. Such analysis visualizes coronary vasculature and 
thus allows for comparative dimensional measurements of the coronary arteries and 
veins. For example, active-fix left-sided leads, which are often guided through the 
coronary sinus and into cardiac veins, are used to pace the left ventricle for heart failure 
patients. In these lead placement procedures, it is important to consider a given patient’s 
vein-to-artery distance because there is risk for arterial perforation if a lead is actively 
fixed in a vein closely aligned with a coronary artery. Another example of a related 
application is the use of the coronary veins for retrograde myocardial drug delivery via 
the coronary venous system. Venous locations near major congested coronary arteries are 
ideal targets for this therapy.  
  This study investigated the unique use of contrast-computed tomography (CT) 
scans obtained from perfusion-fixed human heart specimens for computer-generated 
three-dimensional visualization and analysis of the anatomical features of the coronary 
systems.  The specific aims of this study were to determine which coronary arteries 
coursed near each of the major coronary veins, how close these coronary arteries were to 
coronary veins, and the size of the adjacent coronary arteries.  
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Methods 
Specimen Preparation 
Eleven perfusion-fixed human hearts were modeled and analyzed using the 
Visible Heart Lab’s human heart library at the University of Minnesota. The average 
weight and age of the donors were 86.8 ± 18.9 kg and 55 ± 12 years respectively. Three 
of the specimens had no history of cardiac disease, six specimens had hypertension, one 
specimen had chronic heart failure and cardiomyopathy, and there was no available 
medical history of one of the specimens. 
The specimens were deemed not viable for transplant and were obtained fresh via 
donation through LifeSource Inc. The specimens were cannulated and perfusion-fixed in 
a pseudo-end diastolic state, and preserved in formalin-filled airtight containers[110]. 
Contrast-CT scans were performed on each heart by injecting contrast at 5mL/s into the 
coronary venous and arterial systems simultaneously using venogram balloon catheters. 
Each specimen was scanned in a supine anatomical position. A Sensation 64 multi 
detector computed tomography scanner (Siemens, Munich, Germany) was used at the 
University of Minnesota Fairview Imaging Services, which generated 512 x 512 
resolution images at 0.6mm slice thickness[100]. 
	  
Mimics Segmentation 
CT generated dicom data sets were uploaded to Materialise Mimics® Software 
program (Leuven, Belgium), a computer-modeling platform that allows two-dimensional 
masks to be generated from CT scans using Hounsfield unit thresholds. The masks were 
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used to segment the coronary vessels. Editing of masks was performed to remove areas 
where contrast had leaked into the surrounding tissue. The finished masks were 
reconstructed to create three-dimensional models of the coronary vasculature. 
  
Measurements 
Measurements of relevant vascular parameters were performed in Mimics on the 
four major veins of the coronary venous system: the middle cardiac vein (MCV), the 
inferior veins of the left ventricle (IVLV), the left marginal veins (LMV), and the anterior 
interventricular vein (AIV).  Coursing arteries nearest to each of these veins were also 
analyzed; classification was drawn to the left anterior descending artery (LAD), the left 
circumflex artery (LCX), and the right coronary artery (RCA). Figure 3.2.1 displays an 
example of the three-dimensional reconstructions of the coronary vasculature. 
After three-dimensional models were generated, the number of major coronary 
veins (defined as branching directly from the coronary sinus and over 20mm long) that 
had a nearby (within 5mm) coronary artery was recorded. The name of and the number of 
overlaps for each artery or arteries that were in the vicinity of the vein was also noted. 
Branches of the LAD, LCX, and RCA were broadly classified as their main vessel. 
Centerlines were then calculated for each vessel.  Once centerlines were generated, the 
scans were resliced normal to the centerline of each major vein. Resultant planes 
displayed a normal view of each vein from ostium to terminal end point and were used to 
measure the shortest edge-to-edge distance from the vein of interest to the nearest 
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coursing artery every 5 mm starting from the vein ostium to its terminal endpoint in the 
3-D model. Figure 3.2.2 displays this measurement. 
 
Diameter measurements of corresponding coursing arteries were taken at each 
point where a distance measurement was recorded, but in the plane normal to the arterial 
centerlines. Analysis of measurements was then performed using Matlab Software 
(Mathworks, Natick, MA). Specifically, the percentage of vein-to-artery distance < 0.5 
mm, <1 mm, <2 mm, and < 5 mm corresponding with the perimeter-derived diameter of 
the nearby artery (<1mm, <2mm, or >2mm) was calculated for each major vein. 
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Figure 3.2.1 Anatomical three-dimensional reconstructions 
a) The coronary veins and centerlines generated for MCV, IVLV, LMV, and AIV. b) Left 
Anterior Descending Artery (LAD) and Left Circumflex Artery (LCX) are labeled. c) 
Right Coronary Artery (RCA). d) The coronary arterial and venous systems together in 
space. 
 
 (a)  
(b)  
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(c)  
(d)  
 
 
 
 
 
 
 72 
Figure 3.2.2 Coronary measurements obtained on resliced CT images 
(a) The shortest edge-to-edge vein to artery distance was measured in Mimics as shown 
above. This measurement displays one of the distances taken between the anterior 
interventricular vein (AIV) and left coronary artery (LCA). This measurement was taken 
in a plane normal to the AIV. 
(b) Ellipse measurement taken of the LCA at the location of the meaurement displayed in 
Figure 3.2.2a. The perimeter-derived diameter calculated from the ellipse measurement 
was recorded. This measurement was taken in a plane normal to the LCA. 
(a)  
(b)  
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Results 
Table 3.2.1 presents the relative anatomical parameters of the coronary systems.  
The majority of the coronary veins were within 5mm of a coronary artery somewhere 
along its length. The interventricular veins (the AIV and MCV) elicited the largest 
occurrence of overlaps. There was a large amount of variability in the percentage of each 
vein that coursed within 0.5 mm, 1mm, 2mm, and 5mm of a nearby artery. The left 
marginal veins and the anterior interventricular vein had the largest portion of the vein 
that coursed near a coronary artery. Figure 3.2.3 provides a further breakdown of these 
percentages to include the relative diameter of the adjacent artery. A large proportion of 
the adjacent arteries had diameters over 2mm. 
 
Table 3.2.1 Anatomical parameters quantifying the proximity of the coronary 
arteries to the coronary veins 
Note that columns 3-4 use column 2 as the denominator while columns 5-9 use column 3 
as the denominator. 
 
 
 
Coronary 
Vein 
 
N 
N an 
Artery 
within 
5mm (%)  
% of 
Sample with 
an Arterial 
Overlap 
Average  
# of 
Arterial 
Overlaps 
Average % of  
Vein within 
0.5mm of an 
Artery 
Average % 
of Vein 
within 1mm 
of an Artery 
Average % 
of Vein 
within 2mm 
of an Artery 
Average % 
of Vein 
within 5mm 
of an Artery 
MCV 11 10 (92%)  92% 3.5 ± 1.7 17 ± 21% 28 ± 23% 36 ± 26% 51 ± 27% 
IVLV 18 12 (68%) 61% 1.5 ± 0.9 14 ± 20% 18 ± 23% 33 ± 27% 48 ± 31% 
LMV 16 15 (94%) 80% 1.9 ± 1.9 21 ± 15% 34 ± 20% 55 ± 28% 65 ± 27% 
AIV 11 11 (100%) 100% 3.7 ± 2.1 16 ± 11% 27 ± 12% 44 ± 20% 70 ± 18% 
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Figure 3.2.3 The proximity and size of adjacent coronary arteries to each major 
coronary vein 
Middle cardiac vein (MVC), inferior vein of the left ventricle (IVLV), left marginal vein 
(LMV), and anterior interventricular vein (AIV). 
 
 
 
 
Figure 3.2.4 displays the breakdown of which coronary artery coursed near each 
major coronary vein. The right coronary artery most often coursed near the middle 
cardiac vein in this sample. In two of the specimens, the left anterior descending artery 
coursed near the apical region of the middle cardiac vein. The inferior veins of the left 
ventricle elicited the most variation in adjacent arteries. The left circumflex artery and/or 
branches of the circumflex artery coursed near the left marginal vein in all cases where 
there was an artery near the marginal vein. As expected, the left anterior descending 
artery always coursed near the anterior interventricular vein in this sample of specimens. 
In over a third of cases, the left circumflex artery also coursed within 5mm of the AIV. 
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Figure 3.2.4 Breakdown of the Coronary Arteries Adjacent to the Coronary Veins. 
 Note that this includes branches of the major arteries and that the denominator used to 
calculate the percentages is the total number of veins that coursed within 5mm of an 
adjacent artery. 
 
 
 
Discussion 
This study has provided a novel anatomical database of the coronary vasculature 
of the human heart. The perfusion-fixed specimens were carefully cannulated and fixed 
under a pressure load to ensure dilataion of the vasculature so to allow for subsequent 
contrast injection during CT scanning.  Because these were isolated specimens, 
specialized scanning sequences could be employed without the risk of high radiation 
exposure. 
 The evaluation of human coronary arterial anatomy adjacent to the coronary veins 
is critical when applying therapies within the coronary venous system. For example, 
some left-sided leads are fixed by screwing into the venous wall. As mentioned 
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previously, there is a risk for perforating a nearby artery. The results of this study indicate 
that the left marginal vein, the vein typically utilized in left-sided pacing [29], has the 
highest proportion of the vein that course within 0.5mm of a coronary artery. Figure 3.2.5 
displays an example of a specimen that is at higher risk for arterial perforation: it has a 
marginal branch of the circumflex artery that courses near the left marginal vein. Overall, 
more than two thirds of the arteries that are less that 0.5mm away from the left marginal 
veins have large diameter (greater than 2mm). These results stress the importance of pre-
procedural imaging to identify and subsequently avoid active lead fixation in locations 
near major coronary arteries.  
 The results are also relevant to coronary venous retroperfusion, which has been 
applied to both animal[112-114] and human models[13, 115-117]. For example, 
percutaneous in situ coronary venous arterialization involves bypassing a total arterial 
occlusion using a nearby cardiac vein[13, 117]. The therapy is placed using coronary 
sinus access. Two devices are implanted on either side of the occlusion to connect the 
artery to the coronary vein. Figure 3.2.6 presents an example of a specimen that would be 
ideal for this device; it has multiple overlaps between the left anterior descending artery 
and the anterior interventricular vein. The overall results of the study presented here 
provide insights regarding the probability that the coronary vein and target coronary 
artery are the vein that were not adjacent to a visible major artery, which would limit the 
potential connections between the devices. There was also a fairly high variation in how 
far apart the coronary vessels were, which indicates the need for variable connector 
device lengths. 
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Figure 3.2.5 Example specimen with a marginal branch of the circumflex artery that 
courses near the left marginal vein 
This is a left lateral view of the coronary reconstructions for one of the study specimens. 
The yellow arrow indicates the left marginal veins and the marginal branch of the 
circumflex artery. 
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Figure 3.2.6 Example specimen with a left anterior descending artery that has 
multiple overlaps with the adjacent anterior interventricular vein 
This is an anterior view of the coronary reconstructions for one of the study specimens. 
The yellow arrow indicates the anterior interventricular vein and the nearby left anterior 
descending artery. 
 
 
 Although there is limited literature that quantifies the distance between adjacent 
coronary arteries and veins, previous studies have investigated comparative anatomy 
between the two coronary systems. Maselli et. al [118] used cadaveric specimens to 
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identify which specific artery branch coursed near the anterior interventricular vein and 
coronary sinus as well as which vessel was located closer to the epicardium. Mao et al. 
[72] used patient electron beam computed tomographic angiography to assess the 
prevalence and lengths of arterial overlaps for the anterior interventricular vein, coronary 
sinus, and left marginal vein. The number of overlaps found in the study presented here 
was consistent with these previous publications with the exception of the left marginal 
vein: 80% compared to 20% found in Mao’s study. One possible explanation is that the 
ability to directly inject contrast into the coronary arteries of the perfusion-fixed 
specimen may have allowed better visualization of the distal coronary branches that could 
not be achieved with patient scans.  
 There a few limitations involved with this study that are important to note. First, 
the sample of 11 specimens is not large enough to reach statistical power to compare or 
correlate between the vessel parameters. There is also the possibility that some distal 
vessels were not visualized due to their smaller diameters, which is believed to be the 
case for the specimen that did not have a visible artery near the middle cardiac vein. In 
addition, the specimens were fixed in their maximal end-diastolic state. Hence, each 
vessel population would likely be at their maximal separation from one another. Despite 
these limitations, the results provide useful insights and confirm the large variability in 
anatomy between specimens. 
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3.3. Coronary Sinus Anatomy Relative to the Circumflex Artery 
Julianne H. Spencer, Garrett Prahl, and Paul A. Iaizzo 
 
Preface 
 The inspiration for this study arose from the development of indirect annuloplasty 
devices deployed in the coronary sinus. Annuloplasty is a procedure employed to 
decrease the mitral valve annulus size for patients with mitral regurgitation. The coronary 
sinus typically wraps around the mitral valve. Recently, there have been clinical studies 
testing indirect annuloplasty by deploying a device into the coronary sinus that applies 
pressure to cinch the mitral valve annulus. 
 One limitation of this technology is the risk for coronary compromise. The left 
circumflex, for example, also courses around the mitral valve. The purpose of this study 
is to identify where the circumflex courses between the coronary sinus and mitral valve 
annulus. If pressure is applied from the coronary sinus towards the mitral valve, these 
areas are at risk for compression and potential ischemic effects. 
 For this project, we analyzed magnetic resonance (MR) scans of 65 human hearts. 
The hearts were embedded in gel before scanning to reduce motion artifact and to 
maintain the shape of the specimen. The MR scanner applies a powerful magnetic field to 
the specimen, which causes water protons to align with the field. Next, radio-frequency 
(rf) current is transiently applied to the specimen to create electromagnetic fields. This 
application flips the spins of the water protons. When the rf current ceases, the protons 
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realign with the static magnetic field, which generates a radiofrequency signal that is 
assessed by the scanner’s receiver coils and reconstructed into an image based on 
relaxation times. In this study, images were generated based on an MPRAGE (T1-
weighted) scanning protocol. We chose to use MRI because of its high-resolution for soft 
tissue and because the coronary venous and arterial ostia were properly dilated by our 
laboratory’s gelling technique. 
 For this study, I was responsible for scanning the specimens and developing the 
measurement protocol and analysis. A biomedical engineering student, Garrett Prahl, 
assisted in the majority of data collection and literature search. The preliminary results of 
this study were presented as a poster at the 2013 American Heart Association Conference 
in Dallas this November. 
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Introduction 
Functional mitral regurgitation is the most common form of cardiac valve disease 
[119]. Surgical intervention is the current standard of care treatment for severe mitral 
valve regurgitation. However, the target population is getting older, and many are not 
eligible for surgery. Percutaneous approaches are in development to treat patients that are 
considered high risk for surgery. For example, indirect annuloplasty can be achieved by 
placing a compressing device in the coronary sinus to reduce the size of the mitral 
annulus. However, this involves the risk of compressing the nearby circumflex artery. 
Coronary artery compression has been a concern for indirect annuloplasty 
devices. To date, the main coronary sinus devices that have been tested in clinical trials 
with varying success are Carillon (Cardiac Dimensions)[120, 121], Monarc (Edwards 
Lifesciences)[25], and Percutaneous Transvenous Mitral Annuloplasty or PTMA 
(Viacor)[122, 123]. More specifically, the Carillon device has demonstrated promising 
results for patients that received a permanent implant [120, 121] and is currently 
undergoing additional clinical trials. However, 12.5%[120]-15%[121] of patients were 
not able to receive the device due to coronary compromise. The Monarc device, which 
has been discontinued due to slow clinical trial enrollment [119], reported that 25.4% of 
patients experienced coronary compression due to the device [25]. The PTMA device, 
which was discontinued during the PTOMLEMY II trial due to two device-related 
periprocedural deaths, reported 10% of patients did not receive the device or required 
explantation of the device due to coronary compromise [123]. Further characterization of 
the anatomy of the coronary sinus in relation to the nearby circumflex artery is essential 
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for a better understanding this potential limitation of coronary compression when 
delivering therapies in this anatomical region. 
The primary objective of the present study was to characterize where the 
circumflex artery tends to cross between the coronary sinus and mitral valve in order to 
minimize the occurrence of coronary compression during percutaneous indirect mitral 
valve interventions. Secondarily, we subgrouped the studied specimens relative to 
identified cardiac conditions. This uniquely generated database can be utilized for the 
development of next generation mitral repair devices and other therapy applied within the 
coronary sinus and/or circumflex artery. 
 
Methods 
Study Population 
The coronary sinus, circumflex artery, and mitral valve were assessed for sixty-
five perfusion-fixed human hearts. The hearts were obtained from organ donors whose 
hearts were deemed not viable for transplant and were recovered through a collaboration 
with LifeSource Inc (St. Paul, MN). Each freshly obtained human heart was perfusion-
fixed by cannulating the great vessels and attaching them to an upper delivery chamber of 
formalin while immersed in a lower chamber of formalin [100, 124]. Formalin was 
pumped to the upper chamber to maintain a physiological head pressure for a minimum 
of 24 hours. This method fixed the specimens in an approximation of their end-diastolic 
state. The mean age and weight of the donors in this sample were 57±14 years old and 
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79±20kg respectively. Table 3.3.1 summarizes the cardiac history of the patients from 
which the specimens were recovered. 
Table 3.3.1 Summary of the cardiac history summary of the 65 specimens 
Cardiac History Sample Size 
No history of cardiac disease 23 
Hypertension 34 
Coronary Artery Disease 15 
Atrial Fibrillation 12 
Other Cardiac Disease 13 
 
Magnetic Resonance Imaging 
Magnetic resonance imaging (MRI) scans of each specimen were obtained 
through the University of Minnesota Fairview Imaging Services (Minneapolis, MN). The 
specimens were embedded in a 7% agar solution to maintain their shape and minimize 
motion artifacts [124]. An mprage T1-weighted protocol was performed using a 3 Tesla 
Siemens Trio scanner (Siemens, Munich, Germany) to image the hearts. 
 
Models Generation and Analysis 
 Three-dimensional reconstructions of the coronary sinus and circumflex were 
generated from the scans using Mimics Software (Materialise, Leuven, Belgium). The 
mitral valve annulus was highlighted by creating a three-dimensional spline. Further, the 
locations of where the circumflex artery coursed between the coronary sinus and mitral 
valve were identified. The centroid of the mitral annuls spline was calculated using 
Matlab (Natick, MA). Lines were drawn across the plane of the mitral annulus through 
the centroid so that the annulus was split into anatomical sections as displayed in Figure 
3.3.1 along with the 3-dimensional reconstructions of the coronary sinus and circumflex 
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artery. The posterior region was defined as originating at the ostium of the coronary 
sinus. A binary system was used to indicate if the circumflex artery was present between 
the coronary sinus and the mitral valve within each section. 
Next, the MR scans were resliced along that mitral valve annulus spline. At each 
intersection of the previously generated lines and the mitral annulus, several 
measurements were made in the plane perpendicular to the mitral valve annulus 
including: 
• Distance to the mitral valve from the coronary sinus (CS) and from the left 
circumflex artery (LCX) 
• Distance between the CS and LCX 
• Circumference, long axis diameter, and short axis diameter of the CS and 
LCX 
In addition the distance along the CS and LCX that borders the mitral annulus was 
assessed as well as the angle that encompasses this distance. This angle was calculated 
from three points: the point of the CS or LCX that starts bordering the mitral valve, the 
mitral annulus centroid, and the point of the CS or LCX where the vessel ceases to border 
the mitral annulus. These measurements were also obtained using Matlab and Mimics 
Softwares. 
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Figure 3.3.1 An example of a three-dimensional reconstruction of the relative 
anatomy of the coronary sinus, circumflex artery, and mitral valve annulus for one 
of the investigated human hearts 
The mitral valve annular regions of interest are categorized by the following anatomical 
locations: posterior, left posterior, left, left anterior, anterior, and right anterior  
 
 
Statistical Analysis 
 Vessel overlap prevalence is presented as the percentage of specimens with an 
overlap ± 95% confidence interval. Anatomical parameters are presented as the mean ± 
standard deviation. Wilcoxon rank sum tests were performed to determine if there were 
any anatomical differences between specimens with no history of cardiac disease and 
specimens with a history of hypertension, coronary artery disease, and atrial fibrillation. 
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Results 
The relative spatial anatomy of the coronary sinus, circumflex artery, and mitral 
valve was assessed for each of the 65 specimens. The coronary sinus was present in the 
plane of the mitral valve in 80% of the specimens (52 out of 65). Fifteen percent of the 
specimens had a coronary sinus that was completely elevated above the mitral valve. The 
remaining 5% elicited a coronary sinus that was tilted so that a portion of the vessel was 
within the plane of the mitral valve plane, but the majority of the vessel was elevated 
above the plane. 
Eighty-eight percent of specimens contained a circumflex artery that overlapped 
somewhere between the coronary sinus and mitral valve annulus. Table 3.3.2 presents the 
prevalence of where the circumflex artery coursed in between the coronary sinus and 
mitral valve annulus for the 65 specimens. Figure 3.3.2 illustrates where along the mitral 
valve vessel overlaps were most prevalent. Overlap occurrences were most common in 
the anterior region of the valve annulus and occurred in 69.2% of specimens. Overlap 
prevalence decreased in annular areas more proximal to the coronary sinus ostium. 
Table 3.3.2 The prevalence of where the circumflex artery is present between the 
coronary sinus and mitral valve 
Percentages are displayed with a 95% confidence interval 
Position around 
the Mitral Valve 
Overlap Prevalence  
with 95% Confidence Interval 
Posterior 4.3 ± 5.1% 
Left Posterior 21.5 ± 10.0% 
Left 29.2 ± 11.1% 
Left Anterior 47.7 ± 12.4% 
Anterior 69.2 ± 11.2% 
Right Anterior 7.7 ± 6.5% 
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Figure 3.3.2 A radar graph of the prevalence of circumflex artery overlap 
superimposed over an axial MR scan of one specimen’s mitral valve 
 
 
 
Table 3.3.3 and Figure 3.3.3 summarize clinically relevant anatomical parameters 
of the vessels from this sample associated with various positions around the mitral valve. 
On average, the circumflex artery was closer to the mitral valve than the coronary sinus, 
except for in the anteroleft position. The circumflex artery and coronary sinus coursed the 
closest to one another at the anterior and posterior regions. The circumference and 
diameters of the circumflex artery were smaller than that of the coronary sinus. The 
circumflex vessel parameters decreased from anterior to posterior, while the coronary 
sinus vessel parameters decreased from increased from anterior to posterior. Table 3.3.4 
 89 
shows parameters that describe the extent the vessels surrounded the mitral valve. On 
average, the coronary sinus surrounded more of the mitral valve relative to the circumflex 
artery. 
Table 3.3.3 Various vessel anatomical parameters assessed around the mitral valve. 
(mm) Posterior Posteroleft Left Anteroleft Anterior Anteroright 
CS Distance to Valve 9.0 ± 3.0 12.7 ± 3.3 12.4 ± 3.7 10.0 ± 3.6 9.0 ± 4.0 13.7 ± 13.5 
LCX Distance to Valve 7.8 ± 2.4 10.2 ± 4.1 10.9 ± 4.8 10.7 ± 4.5 8.5 ± 3.8 10.7 ± 3.9 
Distance between CS and LCX 1.6 ± 1.1 4.3 ± 5.6 4.0 ± 4.2 3.9 ± 3.5 2.4 ± 3.0 4.4 ± 8.6 
CS Circumference 39.4 ± 11.3 25.4 ± 5.9 19.9 ± 3.9 18.1 ± 4.0 14.8 ± 3.2 11.2 ± 4.8 
LCX Circumference 8.8 ± 1.9 6.8 ± 2.4 6.9 ± 2.0 7.2 ± 2.3 7.9 ± 2.5 9.4 ± 3.4 
CS Long Axis Diameter 14.6 ± 4.4 9.6 ± 2.1 7.5 ± 1.6 6.7 ± 1.5 5.3 ± 1.3 3.5 ± 1.7 
LCX Long Axis Diameter 3.5 ± 0.7 2.4 ± 0.9 2.6 ± 0.9 2.6 ± 1.0 2.8 ± 0.9 3.5 ± 1.4 
CS Short Axis Diameter 9.1 ± 3.0 5.8 ± 2.1 4.7 ± 1.4 4.6 ± 1.4 3.7 ± 1.1 2.7 ± 1.3 
LCX Short Axis Diameter 1.9 ± 0.5 1.8 ± 0.5 1.8 ± 0.6 1.8 ± 0.5 2.1 ± 0.7 2.4 ± 0.7 
 
Figure 3.3.3 Radar graphs of the anatomical parameters as a function of location 
around the mitral valve 
(A) CS and LCX distance from the mitral valve, (B) distance between the CS and LCX, 
(C) CS and LCX circumferences, and (D) CS and LCX long and short axis diameters 
A.  
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B.  
C.  
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D.  
Table 3.3.4 Distance and angle of the CS and LCX vessel around the mitral valve 
The LCX vessels are categorized into right dominance, where the LCX does not feed the 
posterior ventricular wall, and left dominance, where the LCX courses to the posterior 
side of the heart. 
 
Vessel 
Distance around the MV 
(mm) 
Angle around the MV 
(°) 
CS 102.4 ± 14.7 199.2 ± 16.8 
LCX 68.2 ± 21.3 128.5 ± 43.1 
LCX (right dominance n = 
41) 60.3 ± 18.9 105.4 ± 30.8 
LCX (left dominance n = 
24) 81.5 ± 18.5 167.9 ± 30.6 
 
The Wilcoxon rank sum tests yielded minimal significant differences (p<0.05) 
between healthy hearts and those that were clinically defined to express various diseased 
states in terms of where the circumflex coursed in between the coronary sinus and 
circumflex artery. There were no significant differences indentified in terms of 
prevalence of the coronary sinus in the plane of the mitral valve. Further, there were no 
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significant differences in overlaps between healthy hearts and hearts with a history of 
hypertension. Hearts with a history of atrial fibrillation elicited significantly more 
circumflex artery overlaps in the left region of the valve (p = 0.02) and significantly less 
overlaps in the anterior region (p = 0.01) compared with hearts with no history of cardiac 
disease. Additionally, specimens with a history of coronary artery disease elicited 
significantly more circumflex overlaps in the left anterior region of the mitral valve than 
specimens with no history of cardiac disease. 
It should be noted that there were more significant differences in the 
measurements presented in Tables 3.3.3 and 3.3.4 across the three disease states. All 
three cardiac disease groups have a significantly larger distance to the mitral valve at 
some point along the annulus compared to specimens with no history of cardiac disease. 
The extent that the circumflex artery surrounded the mitral valve in terms of the angle 
between the artery’s beginning and ends points and the mitral valve centroid was also 
found to be significantly smaller for all three cardiac disease states relative to the healthy 
specimens. These subgroup measurements are presented in Appendix C. 
 
Discussion 
To the authors’ knowledge, this is the first study to employ magnetic resonance 
imaging of perfusion fixed human hearts to investigate the spatial anatomy of the 
coronary sinus, circumflex artery, and mitral annulus. Results from our study population 
indicated that overall 80% of the human heart specimens had coronary sinus locations 
that lie in the same plane as the mitral valve annulus. In 15% of the specimens, the 
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coronary sinus was elevated above the mitral valve. If the coronary sinus does not lie in 
the same plane as the mitral annulus, constriction via the vein would have minimal 
chances of constricting the annulus. These findings highlight the clinical importance of 
imaging before interventions to determine whether or not the patient has an elevated 
coronary sinus, which would render the therapy less effective.  
Our anatomical study’s findings also indicated a large occurrence rate (88%) of 
left circumflex artery overlap with the coronary sinus. While the percentage of hearts 
with overlap in posterior and left posterior regions of the heart is relatively low (less than 
25%). The largest occurrence of circumflex artery overlap was in the anterior region of 
the mitral valve. Nearly 70% of these perfusion-fixed specimens had overlap in this 
region. On average, we found the coronary sinus and circumflex artery to course 2.4mm 
from one another while being 8.5-9.0mm from the mitral valve in the anterior area of the 
heart. Therefore, any potential compression of the coronary sinus in this region would 
create a high risk for compromising the circumflex artery, which would override the 
potential benefit of reducing mitral regurgitation and could cause severe patient 
morbidity or mortality risk. 
Previous publications have also investigated the prevalence of circumflex artery 
and coronary sinus overlap. The overall overlap prevalence identified in our study, 88%, 
is in agreement with the range reported in the existing literature even though the 
methodologies employed in these studies are quite varied. Using excised cadaveric 
hearts, Maselli et al [118] reported 63.9% of specimens contained a circumflex artery 
overlap while El-Massarany et al [67] reported 95%. Using patient computed 
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tomography, Nakamura et al [125] reported 96.2% overlap occurrence, Mao et al [72] 
reported an 80.8% occurrence, Choure et al [26] also identified an 80% occurrence, and 
Tops et al [126] reported a 68% occurrence. Recently, Nakamura et al [125] identified the 
specific regions of where such overlaps occurred. Consistent with Nakamura et al’s [125] 
findings, we also identified that these overlap occurred more frequently in the anterior 
regions of the heart. 
The anatomical parameters assessed in our study can be employed as critical 
design inputs into the development of devices that utilize the coronary sinus and/or 
circumflex artery, such as indirect annuloplasty devices. A detailed understanding of 
these vessels’ dimensions, specifically the circumference and diameter, is essential for 
accessing these vessels’ interactions with a delivery system. In the case of mitral valve 
indirect annuloplasty, it is useful to know where the coronary sinus is generally closest to 
the mitral valve. We found that the vein was closest, on average, to the valve at the 
anterior (9.0 ± 4.0mm) and posterior (9.0 ± 3.0mm) regions. However, circumflex artery 
was also closest to the valve and the coronary sinus in these regions. To our knowledge, 
this is the first study to present these specific parameters. It is noteworthy that Nakamura 
et al [125] measured the distance between the vessel and the mitral annular plane, but not 
to the actual mitral annulus as presented here. 
This study has a few potential limitations. The number of anatomical samples 
presented here is not enough to reach statistical power. In addition, our study sample 
contained specimens from patients with varying and progressed states of cardiac disease. 
In the future, a more applicable clinical sample might be one with specimens with a clear 
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primary history of mitral regurgitation. In addition, the dynamic relationship between the 
coronary sinus and left circumflex artery were not incorporated in our measurements 
because the hearts were fixed in their end-diastolic state. However, the number of 
overlaps between the vessels should stay consistent throughout the cardiac cycle. Despite 
these limitations, our findings were consistent with previous publications as described 
above, and there were minimal significant differences between subgroups of varying 
diseased states.  
The information presented in this study may also be useful for clinical 
applications beyond indirect mitral valve annuloplasty. For example, there have been 
reports of circumflex occlusion from radiofrequency ablation in the coronary sinus [127-
129] and circumflex narrowing from coronary sinus balloon occlusion [130]. 
 
Conclusion 
The findings of this study indicate considerations for the design and development 
of annuloplasty devices placed in the coronary sinus. In this sample, there were less 
occurrences of the circumflex artery coursing between the coronary sinus and mitral 
valve annulus in the proximal region of the coronary sinus. In addition, the results stress 
the importance of imaging individual patient cardiac anatomy before performing indirect 
percutaneous mitral valve annuloplasty to avoid impairment to the circumflex artery. Our 
uniquely generated database can be utilized for the development of next generation mitral 
repair devices and any other therapy that can be applied within this regional anatomy. 
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3.4. Coronary Sinus Anatomy Relative to the Mitral Isthmus 
Mark Benscoter, Julianne Spencer, Ryan Goff, Steve Howard, and Paul Iaizzo 
 
Preface 
 Atrial fibrillation (AF) is an arrhythmia where the atrial chambers of the heart 
contract chaotically and inefficiently. Atrial fibrillation can lead to inefficient blood flow 
to the body. One method of treating AF is to ablate areas within the heart that are causing 
the irregular stimulation. Ablation can be performed with various types of energy, 
including radio-frequency, cyrotherapy, and ultrasound. Currently, radio-frequency is the 
most common energy form used for cardiac ablation. 
 The mitral isthmus is an area of the left atrium that is commonly targeted during 
ablation therapy. The mitral isthmus is roughly characterized by a line from the left 
inferior pulmonary vein down to the mitral valve. This area can be ablated via a catheter 
in the coronary sinus. Therefore, an understanding of the relative anatomies of the 
coronary sinus and mitral isthmus is useful for the design of coronary sinus ablation 
catheters. 
 The motivation of this study is to characterize the coronary sinus relevant to 
mitral isthmus ablation. Specifically, we are assessing the coronary sinus ostium 
anatomy, the distance along the coronary sinus from the ostium to the mitral isthmus, and 
the anatomy of the coronary sinus at the mitral isthmus. We have compared these 
parameters between specimens with a history of atrial fibrillation and specimens with no 
history of cardiac disease. We assessed these parameters using magnetic resonance (MR) 
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imaging of 30 perfusion fixed hearts (15 with atrial fibrillation and 12 control). The MR 
imaging method was consistent with the previous study. 
 This study was a group effort lead by Mark Benscoter with myself, Ryan Goff, 
and Steve Howard. As a group, we decided on the parameters to be measured that would 
provide the most useful information in the development of coronary sinus ablation 
catheters. I was responsible for the imaging of the specimens, the development of the 
measurement protocol using Mimics reconstruction software, and a portion of the data 
and statistical analysis. Steve Howard contributed his atrial fibrillation knowledge by 
assisting us in locating the mitral isthmus and general feedback throughout the project. 
Ryan Goff also provided helpful feedback throughout the duration of the project. Mark 
was responsible for the compilation of the manuscript and a portion of the data analysis. 
Cassandra Sundaram and Maria Seewald assisted in the collection of data measurements 
from the MR scans. 
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 Introduction 
The application of ablative therapies within the coronary sinus and the left atrial 
mitral isthmus has been shown to effectively treat atrial fibrillation [131]. The creation of 
a linear lesion at the mitral isthmus is both a common practice and a challenge to 
complete while attempting to achieve electrical isolation [132, 133]. Ineffective ablation 
applications within this region have been reported to be pro-arrhythmic [134]. Thus, 
techniques are continually being explored to decrease this occurrence. When properly 
performed, ablations of the coronary sinus and mitral isthmus are able to create a linear 
set of lesions that terminate conduction pathways for atrial fibrillation (AF) patients[135-
137]. 
In order to carry out effective ablative therapies within the coronary sinus and 
mitral isthmus, physicians must be able to navigate through a highly variable region of 
cardiac anatomy [132, 138, 139]. A detailed understanding of these anatomical structures 
and their relationships to adjoining anatomies is critical (i.e., the circumflex artery, atrial 
myocardial tissue, and/or the endocardial ridgeline between the left pulmonary vein and 
the mitral annulus) [132, 133]. Previous studies have used CT images to characterize the 
morphologies and anatomies in this area during the course of ablation procedures [131, 
134]. Additionally, several previous studies investigated the endocardial surface shape of 
the mitral isthmus, however they have not identified changes associated with cardiac 
remodeling due to AF [132, 134].  
The purpose of this study is to characterize the anatomy that may impact ablative 
therapies delivered at the mitral isthmus. The study utilizes a unique set of MRI 
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anatomical reconstructions of hearts with a history of atrial fibrillation and hearts with no 
history of cardiac disease. The high spatial resolution obtained by MR imaging allows for 
precise analyses of coronary sinus and left atrial anatomy. It is clinically important to 
investigate the potential variation in this regional anatomy to perform more effective 
ablation therapies.  
 
Methods 
Study Population 
Data were gathered from 30 perfusion-fixed human hearts that were considered 
non-viable for transplantation via LifeSource (St. Paul, MN) and the Bequest donation 
program at the University of Minnesota. Heart specimens included those from patients 
with AF (n=15) as well as specimens with no cardiac clinical diagnoses (n=15). Each 
heart was characterized by its size, gender, age, clinical history, and body weight (Table 
3.4.1). A Wilcoxon rank sum test was performed to determine significant (p < 0.05) 
differences between the histories of the AF and non-AF specimens. The AF population 
was older and had a larger male to female ratio, but had similar body weights relative to 
the control group. 
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Table 3.4.1 Study population demographics 
Study population demographics for 30 perfusion-fixed human hearts presented as the 
mean ± standard deviation. 
  
Control  
(n=15) 
Atrial 
Fibrillation 
(n=15) P-Value 
Age (years) 52.8±18.9 71.8±11.1 0.01* 
Gender (male/female) 4/11 9/6 N/A 
Patient Weight (kgs) 76.8±21.8 81.2±24.8 0.65 
*indicates significant difference (p<0.05) 
 
Specimen Preparation and Imaging 
Heart specimens were perfusion fixed with a head pressure of approximately 
50mmHg with 10% formalin as previously described [110]. This allowed the hearts to 
maintain a pseudo end-diastolic shape and thus remain in a more realistic anatomical 
form (Figure 3.4.1). The hearts were then embedded in a 7% agar solution to decrease 
artifact in the magnetic resonance images [110]. Scans of the 30 human hearts were 
performed with a 3T scanner (Siemens TRIO 3T MRI scanner, Munich, Germany) using 
an mprage (T1 weighted) protocol with a base resolution of 512. 
Figure 3.4.1 Example of a perfusion-fixed human heart specimen 
The image on the left shows the anterior surface and the one on the right shows the 
posterior view. 
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Anatomical Reconstructions and Measurements 
Datasets were analyzed using Mimics Software (Materialise, Leuven, Belgium). Each 
cardiac image set was imported and segmented into three-dimensional reconstructions of 
the left atrium and the coronary sinus (Figure 3.4.2). The left atrial reconstruction was 
used to define the mitral isthmus area that would be accessed via a catheter through the 
coronary sinus by using the mitral annulus and left inferior pulmonary vein as references. 
A centerline was generated for the coronary sinus. Anatomical measurements relevant to 
ablation in the coronary sinus (CS) or a mitral isthmus ablation line were assessed. These 
measurements included: 
• CS ostial diameters and circumference 
• Distance along the CS from its ostium to the mitral isthmus  
• CS diameters, circumference, and cross-sectional shape at the mitral isthmus   
• Distance to the left atrium from the CS at the mitral isthmus 
• The presence of fat around the coronary sinus 
The scans were resliced so that the CS ostium was in plane. The CS ostial diameters 
and circumference were measured on this plane. The CS centerline was used to determine 
the distance a catheter would have to travel within the CS to reach the mitral isthmus. 
Next, the scans were again resliced so that the cross section of the CS at the mitral 
isthmus was in plane. The diameters, circumference, and shape of the CS were assessed 
in this plane as well as the distance to the left atrium and presence of fat around the 
vessel. 
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Figure 3.4.2 Anatomical reconstruction of the left atrium (LA), coronary sinus (CS), 
and the left inferior pulmonary vein (LIPV) of a perfusion-fixed human heart. 
The light blue line depicts the centerline of the CS and the yellow line depicts the area of 
the mitral isthmus (MI). 
 
The presence of fat and the distance to the left atrial space was also investigated at 
different positions around the coronary sinus at the mitral isthmus. A line was drawn 
across the mitral annulus as a reference. Next, a line parallel to the mitral annulus was 
drawn across the center of the CS cross-section and defined as 0°. Finally, three 
additional lines were created through the center of the CS cross-sections at 45°, 90°, and 
135° to the 0° line (Figure 3.4.3). The presence of fat between the intersection of these 
lines with the boundary of the CS and the left atrium (LA) was assessed as a binary 
parameter. Then the distance from the coronary sinus to the left atrial space was 
measured at each location around the CS. 
 The location of fat was identified by the variation in contrast seen within the 
MRIs. This was verified by sectioning a heart into 3-5mm thick sections following 
 103 
fixation (Figure 3.4.4). The slices were subsequently MRI scanned to verify that the 
grayscale of the fat around the CS in the scans correlated to the fat seen on the physical 
heart slice. 
Figure 3.4.3 Analysis of fat around the coronary sinus at the mitral isthmus 
The 0 to 180 degree line is parallel to the mitral annulus. Using the center of the coronary 
sinus, 45, 90, and 135 degree lines were created using 0 degrees as the starting point and 
rotating counterclockwise.  The left atrium (LA) and left ventricle (LV) are labeled for 
reference. 
 
 
Statistical Analysis 
Data was presented as the mean ± standard deviation. Nonparametric Wilcoxon 
rank sum tests (α=0.05) were performed to determine if there was statistical difference 
between the AF and non-AF hearts. 
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Figure 3.4.4 Visualization of epicardial fat surrounding the coronary sinus on a 
human heart specimen 
On the left is an MRI image and on the right is a photograph of the same human heart 
specimen. The left atrial endocardial space is labeled. The specimen section includes the 
coronary sinus and immediately inferior to it is a deposit of fat that is visible on both the 
MRI and photograph. 
 
 
 
Results 
Table 3.4.2 summarizes anatomical differences between the AF and non-AF 
patient hearts (n=30). In terms of diameter and circumference, the coronary sinus was on 
average larger at the ostium and smaller at the mitral isthmus for AF specimens relative 
to non-AF specimens. Significant differences between the AF and non-AF hearts were 
identified for the distance along the coronary sinus to the mitral isthmus (p < 0.01), the 
CS long axis diameter at the mitral isthmus (p = 0.03), and the shortest distance from the 
CS to the left atrium at the mitral isthmus (p < 0.01).  
 Figure 3.4.5 summarizes the measurements taken at locations around the CS. The 
overall presence of fat was higher at every position around the CS for the AF specimens 
with the exception of the 270° position. In addition, the 90° and 315° locations were 
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found to be significantly different (p=0.03 and p =0.01 respectively).  The smallest 
percentage of fat for the AF patients was at the 0° location. Altogether, fat was observed 
in 79 out of 135 locations (59%) in non-AF hearts and 109 out of 135 locations (81%) in 
hearts with a history of AF. The average distance from the CS to the left atrial space is 
also larger for the AF specimens at every location assessed around the CS. The 0° and 
315° locations were significantly different (p<0.01 and p=0.02 respectively). The shortest 
distance to the left atrium was the smallest at the 0° and 45° locations. 
 
Table 3.4.2 Coronary Sinus Anatomical Parameters (n=30) 
	  	  
Non-­‐AF	  Hearts	  
(n=15)	  
AF	  Hearts	  
(n=15)	  
p-­‐values	  
(α 	  =	  0.05)	  
	   	   	   	  
CS	  Ostial	  Plane	  Measurements:	   	   	   	  
CS	  circumference	   31.2±10.7mm	   35.2±15.3mm	   0.63	  
CS	  long	  axis	   11.2±4.1	   12.3±6.9	   0.92	  
CS	  short	  axis	   6.8±2.6	   7.3±3.0	   0.69	  
Distance	  from	  Ostium	  to	  Isthmus	  along	  CS	   50.4±14.1	   66.8±14.6	   <0.01*	  
CS	  at	  the	  Mitral	  Isthmus	  Plane:	   	   	   	  
CS	  circumference	   21.3±7.8	   18.1±4.1	   0.09	  
CS	  long	  axis	   8.1±3.1	   6.4±1.7	   0.03*	  
CS	  short	  axis	   4.7±2.0	   4.5±1.4	   0.97	  
	  	  	  	  	  	  CS	  to	  LA	  distances	  at	  Isthmus	   3.4±1.3mm	   5.6±2.0mm	   <0.01*	  
	  	  	  	  	  	  General	  CS	  shapes:	   	   	   	  
	  	  	  	  	  Round	   4	   6	   NA	  
	  	  	  	  	  Oval	   8	   7	   NA	  
	  	  	  	  	  Slit	   3	   2	   NA	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Figure 3.4.5 Average fat distribution (A) and distance to the left atrial space (B) 
around the coronary sinus 
(A) Presence of fat around the perimeter of the coronary sinus. The bar chart compares 
the percentage of non-AF (n=15, blue) and AF hearts (n=15, red) where fat was present at 
different locations around the perimeter of the coronary sinus (CS). (B) Distance between 
different points around to the coronary sinus and the left atrial space for non-AF (blue) 
and AF (red) hearts. The asterisk* indicates a significant difference (p < 0.05) between 
the non-AF and AF specimens. 
A.  
B.  
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Discussion 
Major Findings 
• The average dimensions of the CS at its ostium were larger in AF patients than in 
the hearts with no clinical presentation of AF, but smaller at the plane of the 
mitral isthmus. 
• The average distance a catheter would have to travel to the mitral isthmus via the 
coronary sinus in AF specimens was 50.4±14.1mm, which was significantly (p < 
0.01) longer than non-AF specimens (66.8±14.6mm). 
• The perfusion-fixed hearts that were obtained from AF patients had a higher rate 
of fat present around the CS compared to hearts with no history of AF. 
• The distance between the CS and the left atrial space was larger in AF hearts than 
the non-AF group at every location around the CS. 
• Interestingly, the short axis diameter of the CS in the region of the mitral isthmus 
(4.7±2.0mm) was larger than the commonly available 7 Fr (2.3mm) ablation 
catheter tip. 
 
Clinical Implications 
The use of traditional anatomical landmarks around the mitral isthmus aids in the 
location of an ablation catheter tip within the coronary sinus. However, this may be 
insufficient to achieve an effective lesion necessary for electrical isolation [132]. The 
clinical implications of this research are relevant to ablation procedures. The results 
presented anatomical information regarding CS size, CS length, the presence of fat 
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around the CS, and distance relative to the endocardial surface of the mitral isthmus. 
Each of these parameters can affect catheter placement, tip orientation, and energy 
delivery. The data presented in this study suggest that the ability to create a lesion for AF 
patients could be impacted by an increased presence of fat and a larger distance between 
the CS and the endocardial wall. In addition, Wong et al. [133] found that when 
diameters of the CS at the mitral isthmus are larger than the catheter tip, the catheter tip 
will need to be manipulated many times in order to achieve tissue contact. The relatively 
large average diameter found in this study (short axis: 4.7±2.0mm for AF specimens) 
suggests that it will be challenging to place the catheter tip on the desired tissue to 
achieve a successful ablation therapy. 
The human heart data provided here also indicated that placement of the catheter 
tip aimed towards the LA in a parallel direction to the mitral valve annulus may increase 
the potential for delivery of a successful transmural lesion. The 0° position around the CS 
resulted in the lowest percentage of fat presence (60%) and the second shortest distance 
to the left atrium at 6.0±2.0mm (after the 45° position at 5.8±2.0mm). The ability to 
generate an effective lesion requires that catheters be placed on viable tissue. We 
consider here that better understanding of these parameters will allow for planned 
manipulations of catheters to ensure contact with the desired tissue. In other words, this 
CS-to-device relationship and the knowledge that there are regions around the CS more 
susceptible to the presence of fat suggest that catheter placement within CS makes a 
difference in the creation of an effective lesion set. 
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It should be noted that the focus of this study did not include lesion 
characterizations. However, previous work by Yokokawa et al. [131] demonstrated that 
changes in the ablation settings may be required to achieve a transmural lesion. The 
results of this study showed that there is an increase in the tissue thickness between the 
CS and the left atrium in the area of the mitral isthmus for specimens with a history of AF 
(3.4±1.31mm for non-AF hearts versus 5.6±1.97mm for AF hearts). This, in turn, 
supports the notion that changes to ablation durations and settings may be required to 
result in lesion transmurality.  
 
Limitations 
One potential limitation of our study is that we did not specifically investigate the 
device-tissue interface. Therefore, we consider that additional work is needed to further 
understand how to optimize catheter placement and/or designs, along with the 
corresponding ablation settings, to generate transmural lesions in these anatomical 
locations most effectively and thus improve single procedure success. Another potential 
limitation of the study could be affected by the average age of the AF patients being 
significantly higher than non-AF patients. The study sample size of 30 perfusion fixed 
human hearts was also not large enough to achieve statistical power. 
 
Conclusion 
Ablations in the CS and thus within the left atrium can be very important to the 
overall efficacy and completeness of ablation therapy. Understanding this specific 
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regional cardiac anatomy and how it may be altered within the AF patient population can 
help the physician better utilize (as well as the device designer to optimize) the next 
generation of ablation systems. The outcomes from this study suggest that additional 
consideration is required to create lesions in these anatomies. Specifically, the slightly 
longer lengths of the CS in the hearts obtained from AF patients may suggest that the 
volumes of the left atrium are predicatively larger [132, 134]. In addition, there are clear 
differences in the thicknesses of the myocardial tissues in the regions of the isthmus in 
the AF hearts. Finally, the circumferences of the CS indicate that the ability to affix a 
catheter in the distal areas of the CS may require specific manipulations to ensure the 
catheter tip is in contact with atrial tissue.  
 
 111 
4. Effect of Anatomy on Left Sided Pacing Studies 
 
4.1. Modeling of Induced Electric Fields as a Function of Cardiac 
Anatomy and Venous Pacing Lead Locations [140] 
Sara Anderson, Julianne (Eggum) Spencer and Paul Iaizzo 
 
Preface 
 The motivation of this study was to examine how variations in anatomy affected 
electric fields induced from pacing. Smaller electric fields required to stimulate the 
myocardium reserve battery life and thus prolongs the life cycle of the pacemaker. We 
wanted to determine if certain anatomies, such as diameters, fat thickness, and pacing 
location, affected the pacing threshold. The pacing threshold was defined as the minimum 
voltage required to stimulate the heart. 
Sara Anderson, a previous graduate student in the lab, developed the model and 
collected the model’s input parameters from a previous in vitro pacing swine study using 
the resources at the University of Minnesota Supercomputing Institute. David Bourn 
assisted Sara in developing and analyzing the model. When I joined the lab, I expanded 
upon the model’s parameters and subsequently results and prepared the manuscript for 
publication. Emily Fitch assisted me in literature searches. This study was published in 
The Journal of Cardiovascular Engineering and Technology in 2011. 
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Introduction 
Although transvenous pacing leads were first implanted in the cardiac venous 
system in 1968 [141, 142], initial concerns over potential complications including 
stability, efficacy, stenosis formation, and/or ease of extractability suggested that other 
implant sites be used; thus alternate site pacing was the commonly employed clinical 
protocol until the late 1990s [142, 143]. However, today the use of transvenous leads is 
an integral part of cardiac resynchronization therapy. This therapy is routinely applied to 
correct electromechanical dyssynchronies within the heart by pacing the left ventricle 
(LV) transvenously; it typically involves coordinating right ventricular and right atrial 
pacing as well. 
Cardiac resynchronization therapy has been shown to improve the heart function 
of patients with LV remodeling, wide QRS complexes (>120 ms), and low left ejection 
fractions (<35%), and/or those classified in the New York Heart Association (NYHA) 
classes III and IV [94, 144-149]. While implanting the pacing lead through the coronary 
sinus to the cardiac venous system has proven increasingly successful in treating heart 
failure patients, therapeutic response rates are only about 70% [149-152]. Therefore, a 
better understanding of the effects of varied cardiac anatomies and pacing lead electrode 
positions could ultimately help explain these sub-optimal clinical response rates. 
In a recent study, we employed passive fixation transvenous pacing leads in the 
anterior interventricular veins of isolated swine hearts [65]. Briefly, electrical pacing 
thresholds were measured in three different implant positions: touching the myocardial 
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side of the venous wall (M), not touching any part of the venous wall (F), and touching 
the epicardial side of the venous wall (E; see Fig. 4.1.1). The pacing threshold was 
defined as the minimum voltage required to capture the heart. Pacing thresholds were 
measured in each implant position in at least five implant sites along the vein’s length. 
After fixing each heart, the veins were sectioned in 5 mm intervals perpendicular to the 
vein’s length from base to apex. Standard histological methods were used to prepare 
slides using Masson’s trichrome stains; slides were then digitized (Super CoolscanÒ, 
Nikon, Inc., Melville, NY) and analyzed (Image-ProÒ Plus 4.1.0, Media CyberneticsÒ, 
Bethesda, MD). Measurements were made of each vein’s wall thickness and 
circumference as well as distances between the vein walls and the myocardium [65]. 
Average vein diameters were calculated from measured vein circumferences. 
These histological measurements were then used to develop the electrostatic fields 
model presented here. Thus, simulations of varying vein diameters, distance between the 
vein and myocardial tissue (epicardial fat thickness), and the three electrode positions 
were performed. The resulting electric fields, current densities, and voltage gradients 
were examined to elucidate their effects on pacing thresholds in left ventricular veins. 
We hypothesized that because pacing thresholds were lower when pacing 
electrodes were oriented in the M position, the required electric field would be greater in 
a larger amount of myocardial tissue when compared to the same pacing threshold 
voltage in the E position. As a result, the capture threshold would be lower in the M 
position compared to the E position, i.e., with the same vein diameter and epicardial fat 
thickness. For the same pacing voltage, when the pacing lead was in the E position, it was 
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considered that the electric field dissipated over the distance between the electrode and 
myocardial tissue before enough myocardial tissue could be adequately depolarized. 
Voltage losses across the blood, vein wall, and/or epicardial fat when the pacing lead 
electrode was in the E position in turn result in lower voltages reaching myocardial 
tissue. Thus, a higher pacing threshold would be required to elicit myocardial capture for 
therapeutic pacing in the E position. Additionally, it is considered that the relative effects 
of vein diameter and/or epicardial fat thickness will also affect both pacing thresholds 
and electric fields. 
Figure 4.1.1 Fiberscopic view of the pacing lead within the anterior interventricular 
vein 
The camera view was oriented such that the myocardium is toward the bottom of the 
view [65]. 
 
We believe that a better knowledge of how electric fields propagate through these 
biologic tissues will provide a more in-depth understanding of the effects of vein 
diameters, epicardial fat thicknesses, and/or pacing lead electrode positions on resultant 
pacing thresholds and, importantly, could aid in the design of future transvenous pacing 
leads. The specific aims of this study were to: (1) develop a comparative electrostatic 
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model based on previously obtained histological measurements [65], and (2) compare 
resulting electric fields and voltage gradients with in vitro experimental results [65]. 
Methods 
We used commercially available finite element modeling software Maxwell 3D 
(Ansoft, Pittsburgh, PA) to generate an electrostatic model of the coronary veins. The 
model was designed based on histologic results from the swine hearts measured in 
previous in vitro experiments [65] and material properties found in the literature [153-
159]. The conductivities for all components of the model are displayed in Table 4.1.1. 
Table 4.1.1 Material conductivities 
Material Conductivity (S/m) Source 
Blood 0.63 [153] 
Electrode 8.3E+06 Generalized Medtronic Data 
Insulation 0.07 Generalized Medtronic Data 
Vein Wall 0.81* [154] 
Epicardial Fat 0.05 [155-159] 
Myocardium 0.43 [158, 159] 
*Vein wall conductivity is an average of conductivity in the transverse (0.58 S/m) and 
longitudinal (1.04 S/m) directions 
 
The pacemaker electrode and lead insulation (4 Fr prototype bipolar passive-
fixation left heart lead with 21-mm inter-electrode spacing) were modeled using sizes and 
conductivities consistent with published Medtronic data (Medtronic, Inc., Minneapolis, 
MN). The electrode and lead insulation were modeled as a sphere and cylinder 
respectively with a radius of 0.89 mm. 
The blood volume, coronary vein wall, and surrounding epicardial fat were 
designed as cylinders using histological measurements determined in a previous 
experiment [81]. The venous blood cylinder radius was 1.32 mm, 1.10 mm, or 1.02 mm 
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to model basal, mid, and apical regions respectively. The vein wall was 0.17 mm thick. 
The previous experiment showed that vein wall thickness did not significantly vary along 
the vein length. The epicardial fat thickness was modeled to be 1.16, 1.81, or 0.46 mm for 
the basal, mid, and apical regions respectively, which was previously accessed by 
measuring the distance from the vein to the myocardium [81]. The myocardium was 
modeled to be 8.00 mm from the epicardial fat. 
Pacing thresholds were measured for hearts that were isolated from the body and 
are presented in Table 4.1.2. Nearby anatomical components such as the pericardial fluid 
and pericardium were not a factor in the threshold measurements and therefore were not 
used in this model. Air was also not added as a component due to its low conductive 
properties. 
Table 4.1.2 Pacing thresholds 
Region Pacing Position Pacing Threshold (V) 
Basal E 8.51 
Basal F 7.41 
Basal M 5.66 
Mid E 6.95 
Mid F 5.65 
Mid M 4.28 
Apical E 2.63 
Apical F 4.00 
Apical M 2.28 
 
Figure 4.1.2 shows the cross-sectional and three- dimensional representations of 
the model. The cylinders representing the coronary vein and surrounding tissues were 
20.00 mm in height in the model. The model represents a portion of the vessel. In the 
previous experiments, the coronary vein length ranged from 90 to 135 mm [81]. The 
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components were modeled as stationary. The three different locations of the pacing 
electrode, myocardial (M), free-floating (F), and epicardial (E), were modeled by varying 
the electrode and lead insulation position. 
Figure 4.1.2 Finite element model of a pacing lead in a coronary vein 
(a) Cross-section of the FEA model and its labeled components. The cross-section was 
taken on the xy-plane when z = 0. (b) Three-dimensional view of the model and its 
reference x, y, and z axes. 
(a) (b)  
 
Maxwell 3D software was used to calculate the electric potentials in the 
components of the model from a cathodic input pacing voltages at the electrode and 0 V 
anodic input at the outer myocardial wall. The previously obtained pacing thresholds 
displayed in Table 4.1.2 were utilized as input pacing voltages. The input pacing 
thresholds varied depending on the position within the vein. The pacing voltage charge 
was modeled as uniformly distributed across the electrode surface. The software then 
utilized a DC current flow solver to derive relative electric potentials and electric field 
magnitudes as displayed in Eqs. (1) and (2), respectively: 
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(1)  ∇ • (σ∇φ) = 0  
(2)   E = -∇φ 
where σ = electric conductivity, φ = electric potential, and E = electric field magnitude. 
This approach used adaptive meshing until convergence was obtained; all 
simulations reached a convergence of <1% error. The average number of elements used 
in all simulations was 100k. The myocardial activation electric field was defined as 100 
V/m. In theory, this is the minimum electric field required to activate the myocardium 
[160]. The volume of activated myocardium with an electric field of 100 V/m or above 
was calculated using MATLAB (The MathWorks, Natick, MA). 
 
Results 
The primary purpose of our model was to compare obtained electric field results 
with in vitro experimental data. These simulations were then interpreted in an attempt to 
better understand why pacing thresholds are lower for M-positioned pacing electrodes 
compared to those in either the F or E positions. Furthermore, we used these simulations 
to understand the relative contributions that variations in fat thickness and/or vein 
diameter have on required therapeutic pacing thresholds. 
Figure 4.1.3 shows the induced electric fields on a cross-section of the model as a 
function of pacing lead position. The model indicates that the amount of myocardium 
activated increases from apical to basal venous positions and from lead positioning 
toward the myocardium (M) to away from the myocardium (E). Figure 4.1.4a provides a 
more quantitative view of the amount of activated myocardium between the nine cases. A 
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larger volume of tissue is activated in the E and basal pacing lead positions vs. the M and 
apical positions respectively. Figure 4.1.4b shows the results for the nine cases generated 
from a constant voltage input of 2.28 V, which was the pacing threshold that resulted in 
the smallest volume of activated myocardium. In contrast to the actual pacing threshold 
results shown in Fig. 4.1.4a, the constant voltage input resulted in larger myocardial 
activation volumes for apical vs. basal positions. The M positions result in slightly larger 
volumes of activated myocardium compared to the E positions. 
Figures 4.1.5a–5c show the electric field as a function of location along the y-axis 
for the apical, mid, and basal models respectively. The largest electric field drops 
occurred in both the blood and epicardial fat. This figure shows that relative to the 
electric field magnitudes in the rest of the components, the electric field in the 
myocardium was similar among the pacing positions. 
 
 
 
 
Figure 4.1.3 Visual representations and one-dimensional plots of electric field 
magnitudes on the xy-plane where z = 0 
(Following page) The left, middle, and right columns show visual representation of the 
electric field magnitudes when the lead is positioned toward the myocardium (M), free-
floating (F), and away from the myocardium (E), respectively, for pacing threshold 
measured in vitro. The top, middle, and bottom rows show the modeled electric fields 
when the lead is placed in basal, mid, and apical regions of the heart. Red indicates 
activated myocardium (tissue with an induced electric field of 100 V/m or greater). 
Greater activation fields are generated when the lead is positioned toward the 
myocardium and in more apical regions. Each electric field threshold is denoted at the 
bottom of the respective graph. Pericardial fluid and pericardium are to the right; 
myocardium is to the left. 
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Figure 4.1.4 Volume of activated myocardium 
Volume of activated myocardium as a function of lead position using (a) previously 
measured physiological pacing thresholds, and (b) a constant voltage input of 2.28 V. In 
(a), the volume is greater for basal regions than in apical regions. The volume of 
activated myocardial tissue increases from pacing leads oriented toward the myocardium 
(M), to pacing leads oriented away from the myocardium (E). Free- floating (F) pacing 
lead positions activate less tissue volume than E positions, but greater volumes than M 
positions. In (b), the activation volumes increase from the basal regions to the apical 
regions and slightly decrease from the M position to the E position. 
(a)  
(b)  
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Figure 4.1.5 Electric field magnitudes by component 
(a) Electric field magnitude along the y-axis for the apical models. The x-axis indicates 
the associated model component. (b) Electric field magnitude along the y-axis for the mid 
models. The x-axis indicates the associated model component. (c) Electric field 
magnitude along the y-axis for the basal models. The x-axis indicates the associated 
model component. 
(a)  
(b)  
(c)  
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Discussion 
This computational study provides two principal findings as a result of comparing 
electric fields and voltage gradients by utilizing in vitro obtained experimental input 
parameters: (1) smaller electric fields were present when the pacing lead electrode was 
oriented toward the myocardium (M position) compared to when the electrode was free-
floating or oriented away from the myocardium (F or E positions), and (2) with 
increasing vein diameters and fat thicknesses, higher pacing thresholds (therefore, larger 
electric fields) will be required to consistently pace the underlying myocardium. 
 
Pacing Lead Positions 
Throughout a given vein, derived electric fields for pacing were smaller when 
lead electrodes were in the M position relative to those in F and E positions. In contrast, 
the results from a constant pacing input show the opposite response as seen in Fig. 4.1.4b. 
This suggests that the differences in activated myocardium volume are dependent on the 
pacing thresholds that were measured previously [65]. As indicated by the electric field 
equaling 0 within the conductor and charge present only on its surface, the electrode is a 
conductor. It was also determined that blood was less conductive than the electrode and 
therefore a decrease in electric field occurs between the electrode and the vein wall. The 
vein wall is typically slightly more conductive than blood, thus the charge will be present 
on the outer surface of the vein wall. 
Thus, increases in pacing threshold for the free-floating (F) and away from the 
myocardium (E) positioning vs. toward the myocardium positioning (M) are most likely 
 124 
caused by the voltage and electric field drops that occur in the blood as seen in Fig. 4.1.5. 
For example, when the pacing lead is in the M position, the pacing pulse does not need to 
travel through blood before reaching the vein wall, the epicardial fat, and finally the 
myocardium. However, in both F and E electrode positions, the pacing pulse must first 
travel through blood and through vein wall and epicardial fat before reaching myocardial 
tissue. On the other hand, the electric field magnitudes are relatively similar along the 
myocardium if compared to those of the other model components. Note that the electric 
fields in the myocardium did not exceed 350 V/m (which is consistent with the order of 
the theorized 100 V/m activation field [160]) in any of the cases. 
 
Effects of Fat Thickness and Vein Size 
Leads positioned in the basal regions of the heart, which have larger fat 
thicknesses and vein diameters, produced larger activating electric fields than those 
positioned in apical regions with smaller fat thick- nesses and vein diameters, as seen in 
Fig. 4.1.4a. Again when a constant pacing stimulus was applied to all models, the 
opposite result occurred. This again suggests that the volume of activated myocardium is 
dependent on the pacing threshold [65]. One explanation for the difference in pacing 
thresholds is the variation in the alignment of the cardiac myocytes. Studies have shown 
that the conductivity of the myocardium is greatest in the direction of the myocardial 
fibers [161-163]. The myocytes in the apical areas of the heart may be aligned in a 
manner that increases the conduction of the applied pacing signal relative to that of basal 
areas. 
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Optimal Lead Placement 
According to our model, optimal lead placement will likely occur in apical 
regions of the heart with the lead electrode placed toward the myocardium. Smaller 
induced electric fields indicate more efficient capture and longer battery life. Yet, it 
should be noted that clinically it is believed that optimal LV ventricular lead placement 
occurs on the site of latest activation, which may not be in the apical regions [91, 150, 
151, 164-166]. However, the optimal pacing site will vary significantly from patient to 
patient [91, 167]. Nevertheless, we consider that the first iteration of this model presented 
here provides novel insights regarding the electric fields resulting from different pacing 
positions along the entire length of a given LV vein. Thus, this model could serve as the 
basis for future cardiovascular research including modeling how pacing leads move 
within the coronary veins with each contraction, how stenosis may affect pacing 
thresholds, evaluation of different electrode and lead designs, and what pacing positions 
can be used to avoid phrenic nerve stimulation. 
 
Limitations 
The anterior interventricular vein was used to obtain swine pacing thresholds 
because of its accessibility with the Visible Heart ® apparatus design. Additionally, the 
computational model employed here was comparative, employing simple half cylindrical 
shapes and isotropic tissue conductivities. In reality, biologic tissues are not isotropic and 
vary considerably within a given vessel and/or between individuals [81, 162]. Cardiac 
tissue conductivity has been shown to be higher in the direction of fiber orientation [161-
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163]. It should also be noted that due to the use of the half cylindrical shapes, fringe 
effects were observed at the junctions between different materials (Fig. 4.1.3). 
In addition, all tissue conductivities used here were obtained from literature 
sources in which healthy sample populations were studied (Table 4.1.1), thus 
pathological or aging effects need future consideration. Furthermore, the relative in vitro 
pacing parameters and associated anatomical histologic measurements entered into this 
computational model were those from healthy swine hearts; to date, no similar human 
data are available.  
However, the purpose of this model was to compare measured in vitro pacing 
parameters from these healthy swine hearts with model results. It should be noted that we 
recently reported on human heart microanatomical measurements [81]; these 
measurements were taken from diseased hearts, and it is not known if such patients 
would have required cardiac resynchronization therapy. Nevertheless, in future 
computations one could easily modify input geometries of the model and/or analyze other 
varying criteria, including diseased myocardial tissue or fatty and/or fibrotic deposits 
within the myocardium. 
Finally, this computational model was considered in the steady state, and we 
know that relative anatomical features will change throughout the cardiac cycle and are 
not identical to the input parameters obtained from our in vitro experiments. 
Nevertheless, due to the transient nature of myocardial cells (peak depolarization occurs 
at approximately 2 ms) [168], one can consider that this initial model is a good 
approximation of the electric fields immediately after a pacing stimulus is delivered. 
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Conclusions 
The resultant modeled electric fields followed the same qualitative trends as those 
obtained from in vitro experiments performed in our laboratory: smaller electric fields 
were present when the pacing lead electrode was oriented toward the myocardium, 
relative to being positioned centrally in a vein or away from the myocardium. Lead 
position, vein diameter, and/or epicardial fat thickness influenced therapeutic pacing 
thresholds. With increasing vein diameters and fat thicknesses, higher pacing thresholds 
(and therefore larger electric fields) will be required to consistently capture myocardial 
tissue. In this model, the amount of activated myocardial tissue was dependent on pacing 
position due to the distance to the myocardium and conduction pathways, voltage losses 
in the blood, and/or electrode contact with the vein wall. In conclusion, the described 
electrostatic field simulations may provide novel insights as to how cardiac anatomy and 
lead electrode location will ultimately affect clinical pacing thresholds by providing 
relative visualization of the electric fields propagating through cardiac tissues during an 
applied pacing pulse. 
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4.2. Phrenic Nerve Stimulation in vivo 
Julianne Spencer and Paul Iaizzo 
 
Preface 
 The prevention of phrenic nerve stimulation is one of the current challenges in 
cardiac resynchronization therapy as previously discussed. The main motivation of this 
study is to determine the effect of anatomy on phrenic pacing thresholds. We will 
determine the correlations using regression statistics and electric field finite element 
analysis (FEA), similar to the model presented in Chapter 4.1. The pacing threshold 
inputs to this FEA model were obtained in-situ in a swine model. Venous anatomy was 
obtained via magnetic resonance imaging of the pacing site. Finally, a finite element 
model was developed based on these parameters using Maxwell Software. It should be 
noted that the voltage drops along the pacing lead conductor were not taken into account 
in the model results presented here. However, we plan to incorporate these voltage drops 
into the model before submitting the study for publication. 
I was responsible for the protocol design, data collection and analysis, and electric 
field model generation. I was grateful to receive assistance from Paul Iaizzo and Tinen 
Isles during in situ data collection as many of the swine had difficult-to-access venous 
anatomy. 
	  
 
 129 
Introduction 
The potential for undesired phrenic nerve stimulation remains one of the current 
clinical challenges associated left ventricular pacing. Cardiac resynchronization, which 
involves pacing the left ventricle from a lead implanted within a coronary vein, has been 
shown to improve moderate to severe heart failure [94-97]. The left phrenic nerve 
typically courses around the left ventricle and then stimulates the left side of the 
diaphragm. If a left ventricular lead is implanted in a vein near this nerve, undersired 
phrenic nerve stimulation can occur at cardiac pacing stimulation voltages. Phrenic nerve 
stimulation has been reported to occur in over a third of these patients during implant or 
follow up [30]. 
It is well accepted that phrenic nerve stimulation is dependent on the nerve’s 
proximity to the pacing lead electrode and the magnitude of the electric field delivered by 
the pulse generator [169]. The primary purposes of the present study were to (1) 
investigate additional anatomical parameters that may affect phrenic nerve stimulation 
and (2) model the induced electric fields required to stimulate the phrenic nerve. The 
parameters incorporated into this models were developed by measuring in situ phrenic 
nerve pacing thresholds in animal studies, analyzing the anatomy of the pacing site using 
magnetic resonance, and modeling the resultant electric fields with finite element analysis 
(FEA). The electric field model is an iteration of a previously published transvenous 
pacing model [140] with the addition of the phrenic nerve, lung tissue, the pericardium, 
and pericardial fluid. 
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Methods 
In-Situ Procedure 
Four anesthetized Yorkshire swine animals were used in this study. All protocols 
followed the standards indicated in the “Guide for the Care and Use of Laboratory 
Animals” (NIH). First, an intramuscular injection of telazol was administered to initially 
sedate the animal followed by an intravenous (IV) application of methahexanol using an 
IV Jelco catheter (Johnson & Johnson, Arlington, TX). Each animal was then intubated 
and mechanically ventilated. Subsequently, general anesthesia was maintained with 
isofluorane for the duration of the study.  
A medial sternotomy was performed. Once the chest was opened, the phrenic 
nerve was located and a nearby vein was identified. The sternum was reclosed using 
towel clamps to prevent alteration of the anatomy of these structures. The cardiac venous 
system was accessed by placing a catheter through the jugular vein, superior vena cava, 
right atrium and coronary sinus. A prototype active-fixed left-sided lead was then 
implanted within the target coronary vein using fluoroscopy (Ziehm Imaging, 
Nuremberg, Germany). 
The pacing threshold required to stimulate the phrenic nerve was measured using 
a 2090 Analyzer (Medtronic, Mounds View, MN). Impedance measurements were also 
noted to validate there was no damage to the prototyped lead. Phrenic nerve stimulation 
was identified by visible contraction of the diaphragm and/or palpitation. The threshold 
and impedance were measured for 0.4 ms duration pulses and for two electrode 
configurations: LV tip to LV ring and LV ring to LV tip. 
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After measuring the pacing thresholds, the location of the lead tip electrode was 
marked by placing a suture at these locations through the pericardium directly into the 
cardiac tissues. The phrenic nerve was also sutured to the heart. After the sacrifice of the 
animal, the myocardium and associated tissues containing the pacing site and phrenic 
nerve were excised. Each tissue sample was fixed in 10% buffered formalin. The phrenic 
nerve diameter was assessed with calipers. 
 
Magnetic Resonance Imaging (MRI) and Image Analysis 
To prepare the tissue samples for the MRI scans, thin silicone tubing was glued 
onto the phrenic nerve and at the pacing lead tip site to highlight these anatomies under 
the magnetic resonance imaging. Each tissue sample was then embedded in agar gel to 
reduce artifact as previously described [110]. Next, imaging was performed using an 
mprage (T1 weighted) protocol with a base resolution of 512 was performed on a 3 Tesla 
Siemens TRIO scanner (Munich, Germany). 
 Mimics software (Materialise, Leuven, Belgium) was used to reconstruct the 
anatomy from the obtained MR dicom files. Reconstructions of phrenic nerve, coronary 
vein, and pacing lead tip marker were generated for each sample. A centerline was 
calculated for the venous reconstruction and the scans were resliced normal to this 
venous centerline. On the slice where the lead tip marker was visible, the following 
anatomical measurements were made: venous diameter, epicardial fat thickness, and 
distance to the nerve. The epicardial fat thickness measurement was taken in the direction 
of the nerve. An example of these measurements is demonstrated in Figure 4.2.1. The 
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same measurements were made on the plane 21mm proximal to the coronary sinus. This 
is an estimate of where the ring electrode was approximately located during the in situ 
experiment since the tip and ring electrodes were spaced 21mm apart on the prototype 
lead. 
Figure 4.2.1 Anatomical measurements made on the MRI scan at the pacing site of a 
tissue sample. 
The scan was resliced perpendicular to the coronary vein. The tip electrode marker 
indicated that this was the location of the lead tip within the vein. The fat thickness 
measurement was taken in the direction towards the phrenic nerve. 
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 The shortest distance between the pacing lead tip and ring electrodes and the 
nerve was assessed separately since the shortest distance was not necessarily on the two 
planes that the previous measurements were made. A centerline for the phrenic nerve 
reconstruction was generated and imported into Matlab software (Mathworks, Natick, 
MA) along with point locations of the electrode positions to calculate the shortest 
distance between the electrodes and the nerve. 
 
Electric Field Modeling 
 Maxwell 3D Software (Ansoft, Pittsburgh) was used to model phrenic nerve 
stimulation induced by pacing from a coronary vein. The model was developed using the 
previously described measurements obtained from MRI scans and material properties 
found in the literature. The material conductivities employed are presented in Table 4.2.1.  
Table 4.2.1 Material conductivities obtained from the literature. 
*Vein wall conductivity is an average of conductivity in the transverse (0.58 S/m) and 
longitudinal (1.04 S/m) directions. 
**Myocardial conductivity is the average conductivity in the fiber direction (0.7 S/m), 
parallel to myolaminae (0.35 S/m), and normal to the myolaminae (0.16 S/m).  
Material Conductivity (S/m) Source 
Blood 0.63 [153] 
Electrode 8.30E+06 Generalized Medtronic data 
Insulation 0.07 Generalized Medtronic data 
Vein Wall 0.81* [154] 
Epicardial Fat 0.05 [156] 
Myocardium 0.40** [162] 
Pericardial Fluid 1.41 Vhlab data 
Pericardium 1.00E-08 [170] 
Nerve 1.00 [171] 
Lung 0.042 [172] 
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 Figure 4.2.2 displays the resultant simplified finite model. An overall 60mm by 
60mm width and height tissue model was chosen to ensure that the phrenic nerve was 
incorporated in the model for all four trials. The prototype lead was 4Fr with 5 Fr 
electrodes. The tip electrode was estimated as a sphere while cylinders represented the 
lead body and ring electrode. Further, the dimensions of the venous wall (0.173mm) 
[140], pericardial fluid (0.5mm) [170], and pericardium (1.5mm) [170] were obtained 
from the literature. Cylinders also represented the blood volume and fat thickness with a 
diameter measured in the in situ study and presented in the results. A half-cylinder was 
used to represent the nerve on the pericardial surface. The nerve was positioned on in the 
model using the distance from each lead electrode measured on the plane normal to the 
coronary vein. The pacing thresholds measured in situ were applied as model excitations. 
The electric field required to stimulate the phrenic nerve was quantified by measuring the 
highest electric field magnitude on the nerve’s surface. 
Maxwell software was used to compute the electric potentials for each component 
of the model using the direct current flow solver, which solves Equation 1. The software 
used adaptive meshing until a convergence of <1% error was obtained. The program then 
calculated the electric field magnitudes using the derived electric potentials in Equation 
2. 
 
∇ ⋅ (σ∇Φ) = 0  (1) 
E = -∇Φ  (2) 
where σ  = electric conductivity, Φ  = electric potential, and E = electric field magnitude. 
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Figure 4.2.2 Finite element model of a left-sided pacing lead and a nearby phrenic 
nerve 
(a) Cross-section of the FEA model with its labeled components. (b) Three-dimensional 
view 
(a)  
 
(b)  
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Statistics 
 Multiple linear regression analyses were performed to determine which 
anatomical parameters correlated with the phrenic nerve pacing thresholds (Minitab®, 
State College, PA) using a significance level of α < 0.05. The generated electric field 
magnitudes were summarized as the mean ± standard deviation. 
 
Results 
In situ Pacing Thresholds 
 Table 4.2.2 presents the measured anatomical measurements and pacing 
thresholds for this series of studies.  A multiple linear regression analysis was performed 
for the nerve diameter (p = 0.08), venous diameter (p = 0.10), fat thickness (p = 0.08), 
and distance to the nerve (p = 0.05*).  The resulting regression line that predicts the 
threshold to stimulate the phrenic nerve is displayed below in Equation 3. 
 
Threshold = 12.6 – 8.39*Nerve Diameter + 2.79*Vein Diameter – 3.22*Fat Thickness + 
0.21*Electrode Distance to the Nerve                                  (3) 
 
Figure 4.2.3 displays the observed versus predicted phrenic nerve stimulation thresholds. 
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Table 4.2.2 Anatomical parameters and thresholds required to activate the phrenic 
nerve in situ. 
 
 
Trial 
 
Nerve 
Diameter 
(mm) 
 
Venous 
Diameter 
(mm) 
 
Fat 
Thickness 
(mm) 
Shortest 
Distance to 
Nerve from 
Tip 
Electrode 
(mm) 
Shortest 
Distance to 
Nerve from 
Ring 
Electrode 
(mm) 
PNS 
Threshold 
with Tip as 
Cathode 
(V) 
PNS 
Threshold 
with Ring 
as 
Cathode 
(V) 
1 1.8 1.4 0.7 30.1 21.431 6.0 2.8 
2 2.0 2.4 0.5 28.0 12.9 6.2 4.5 
3 1.6 1.3 0.5 26.4 24.0 8.2 6.2 
4 1.5 2.5 2.0 29.4 13.8 6.6 2.9 
 
 
Figure 4.2.3 Predicted versus observed thresholds 
A scatter plot of the predicted versus observed thresholds is displayed. The predicted 
thresholds were calculated from the multiple regression equation (Equation 3). The linear 
regression trendline for this scatter plot is also shown below. 
 
 
 
Electric Field Model 
 The plane where the phrenic nerve borders the pericardium resulted in the highest 
electric fields, which are displayed in Figure 4.2.4. The mean electric field required to 
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stimulate the phrenic nerve was calculated to be 183.3 ± 82.1V/m. Although these fields 
are not visible in the figure, it was also confirmed that the myocardium component had an 
electric field greater than 100V/m indicating myocardial stimulation [160] since the 
myocardium was also being captured at the phrenic nerve pacing threshold during each 
trial in the in situ study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.4 Generated electric field magnitudes displayed on the plane containing 
the border of the phrenic nerve and pericardium 
(Following page) The location of the plane is illustrated at the center left of the figure. 
The top four images represent the when the tip electrode was applied as the cathode while 
the bottom four images represent when the ring electrode was applied as the cathode. The 
phrenic nerve pacing thresholds and maximum electric field magnitude on the nerve’s 
surface are also shown. 
 139 
 
 
 140 
Discussion 
The results of this analysis indicated that the distance between the cathode and the 
phrenic nerve was the only anatomical parameter to reach statistical significance (p = 
0.05) relative to its relationship with the phrenic nerve pacing threshold. The electrode 
distance to the nerve had a positive coefficient in the regression model. As expected, a 
nerve that is farther from the stimulating electrode requires a high pacing threshold 
because the stimulus has to travel a further distance and is attenuated by the surrounding 
tissue. This finding is consistent is previous reports [169]. 
 Although the rest of the parameters did not reach statistical significance, the 
multiple regression analyses provide some interesting insights. Larger nerves correlated 
(p = 0.08) with lower thresholds suggesting that large nerves may be easier to stimulate 
from venous pacing positions. On the other hand, smaller venous diameters correlated (p 
= 0.10) with lower thresholds, which is consistent with previous publications [65]. 
Interestingly, larger fat thicknesses were also correlated (p = 0.08) with a decrease in 
phrenic nerve activation thresholds. This latter result contrasts with previous findings that 
larger fat thicknesses attenuate pacing stimuli [140]. A possible explanation for this result 
is the apparent presence of non-uniform fat thicknesses around the coronary veins in the 
tissue samples. 
 The multiple linear regression analysis yielded an R2 value of 0.87, which implies 
that the analysis accounts for 87% of the variance in the experimentally observed phrenic 
pacing threshold. This implies that there could be additional parameters that affect the 
pacing threshold or the variances was also associated with the experimental limits of our 
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investigation. One additional parameter that may have affected the threshold, but was not 
included in the present study, is fiber orientation of the myocardium. The conductivity of 
the myocardium is highest in the direction of the fibers [162]. A fiber orientation in line 
with the path to the phrenic nerve from the stimulating electrode may reduce the 
threshold required to activate the nerve. 
 To the authors’ knowledge, there is limited literature available that describes the 
electric field magnitude required to stimulate the phrenic nerve. In addition, there are 
different electric field magnitudes reported to stimulate various nerves. The FEA model 
presented here found that an average electric field magnitude of 183.3 ± 82.1V/m was 
required to activate the phrenic nerve from a pacing lead within a coronary vein. This 
result is consistent with a previous report that cited an electric field on the order of 
100V/m is required to stimulate cortex nerves to produce muscle twitches in the hands 
[173]. In contrast, there have been studies [174, 175] that report an electric field 
magnitudes between 3.8 and 5.3 V/m induced from magnetic resonance imaging can 
stimulate peripheral nerves.  It may be valuable to further investigate if peripheral nerves 
can be stimulated by lower electric field magnitudes. 
 There are limitations to this study in addition to those already described (non-
uniform epicardial fat thickness and the disregard of myocardial fiber orientation). The 
sample size was low (n=4) primarily due to the complexity of the employed experimental 
and imaging protocols. In addition, the resultant FEA model included several 
simplifications of the cardiac anatomy. The model incorporated basic geometries 
resulting in a constant venous diameter throughout the model. In addition, the lead was 
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oriented in the center of the model. Anderson et al [65, 140] demonstrated that the 
orientation of a lead within the vein could have an impact on pacing thresholds. Also, 
minimal validation was performed on the model involving the confirmation that the 
model solutions also indicated that the myocardium was stimulated with an electric field 
magnitude greater than 100 V/m. Finally, the model was considered to be in a steady 
state and did not take into account anatomical changes that occur throughout the cardiac 
and respiratory cycle. Similar to the first iteration of this model [140], the results can be 
considered an estimate of the electric fields present immediately after a stimulus has been 
delivered from a pacing lead within the coronary vein. In future work, the 
aforementioned limitations could be addressed in the next iteration of the presented FEA 
model. 
 
Conclusions 
The principle findings identified in this study are: (1) the distance between the 
cathode and the nerve was the most significant predictor of phrenic nerve stimulation 
thresholds and (2) the electric field magnitude required to stimulated the nerve was in the 
range of 183.3 ± 82.1V/m. The novel experimental data obtained and the model 
developed from them provide useful insight into the anatomical parameters one needs to 
consider clinically to avoid phrenic nerve activation.  The provided information could be 
utilized by both physicians and design engineers to develop strategies to avoid undesired 
diaphragmatic activation during left-ventricular pacing from the coronary venous system. 
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Thesis Summary 
The anatomy of the coronary venous system has important implications for 
clinical interventions (Chapter 1). Physiologically, the system is a highly variable 
network of veins that drain deoxygenated blood from the myocardium. The coronary 
veins are composed of 1) the greater cardiac system, which carries the majority of the 
deoxygentated blood to the right atrium, and 2) the smaller cardiac system, which drains 
the blood directly into the heart chambers. The coronary veins are currently being used 
for several biomedical applications including but not limited to cardiac resynchronization 
therapy, ablation therapy, defibrillation, perfusion therapy, cell delivery therapy, and 
mitral valve annuloplasty. For the clinician and the medical device designer, an in depth 
knowledge of coronary venous anatomy is essential for optimal development and 
delivery of treatments that utilize this vasculature. 
Coronary venous anatomy was characterized using perfusion-fixed cardiac 
specimens with direct measurements using a microscribe digitizer (n=18) and with 
contrast-computed tomography scans (n=121) (Chapter 2). Clinically relevant anatomical 
parameters, such as arc length, branching angle, tortuosity, and ostial diameters, were 
assessed. It is important to note that there was a high variation both across the study 
population reflected in large standard deviations and in the overall population reflected 
by large tolerance intervals. In this sample, there were no consistent significant 
differences in venous anatomy between various cardiac disease states (heart failure, 
hypertension, atrial fibrillation, and coronary artery disease) and specimens without a 
history of cardiac disease. Nevertheless, the resultant library of obtained contrast-CT 
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images of perfusion-fixed human hearts will serve as an important resource for both 
medical device designers and those delivering such therapies. 
The database of coronary venous anatomy was subsequently expanded to include 
the system’s relationship with the surrounding anatomy (Chapter 3). For example, the 
phrenic nerve, which can be inadvertently stimulated during cardiac resynchronization 
therapy, coursed the closest to the middle cardiac vein and the left marginal vein (the vein 
typically used for left-sided pacing). The phrenic nerve overlapped the left marginal vein 
in over half of the specimens in the sample, which is may be a factor in the clinically 
reported 37% phrenic nerve stimulation rate during left-sided pacing via the coronary 
veins. The distance between the coronary veins and the coronary arteries was also 
assessed to address implications for active-fix left-sided leads, coronary venous drug 
delivery, and indirect percutaneous mitral valve annuloplasty. For example, the 
circumflex artery tended to course between the coronary sinus and mitral valve in the 
anterior region of the heart, which suggests that a mitral valve annuloplasty device with 
constrictions in the posterior/inferior region (versus the anterior region) of the coronary 
sinus may be at lower risk for compressing the nearby circumflex artery. Finally, 
significantly longer coronary sinus lengths and distance to the left atrial space at the 
mitral isthmus were identified for specimens with a history of atrial fibrillation, which 
has direct implications for providing ablation therapy in this region. 
The described electrostatic field simulations provided novel insights into to how 
cardiac anatomy and pacing electrode location will ultimately affect clinical pacing 
thresholds and phrenic nerve stimulation by providing relative visualization of the 
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electric fields during an applied pacing pulse (Chapter 4). These unique computational 
models demonstrated that pacing positions oriented toward the myocardium with smaller 
vein diameters and fat thicknesses resulted in lower volumes of stimulated myocardium. 
The phrenic nerve in situ and modeling study indicated that the distance to the phrenic 
nerve was the most significant anatomical indicator of phrenic pacing thresholds and that 
an electric field of approximately 183.3 ± 82.1V/m is required to stimulate the phrenic 
nerve. 
 In short, the human coronary venous system is a highly variable physiological 
system that is essential for several current cardiac therapies. The consistent observation 
of a high degree of anatomical variation throughout all of the performed studies presented 
in this thesis stress the clinical importance of understanding a given patient’s individual 
anatomy when performing a planned intervention in the coronary veins. Importantly, the 
coronary venous database of anatomical parameters and pacing thresholds presented here 
can be incorporated into the development and implementation of therapies that utilize 
these vessels. 
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Appendix A: Additional Published Coronary Work 
 
A1. Novel Imaging of a Left-sided Lead Implant in a Reanimated Swine 
Heart 
Julianne (Eggum) Spencer and Paul Iaizzo 
Published abstract in the Federation of American Societies for Experimental 
Biology Journal (2012) Ab140 
 
Objective: To obtain unique images of left-sided pacing lead implantations for the 
educational benefits of both physicians and medical device design engineers.  
Methods: We employed Visible Heart® methodologies[176] to obtain simultaneous 
videoscopic (internal and external) and flouroscopic footage of the device-tissue 
interfaces during left-sided pacing lead (Medtronic 4196 4F dual electrode lead) 
implantations within reanimated swine hearts. We targeted the lateral cardiac veins via 
delivery through the coronary sinus. We used an isolated cardiopleged heart from 
Yorkshire-cross swines; the University of Minnesota’s Animal Care and Use Committee 
approved all experimental protocols involved in this study. 
Results: Figure A1.1 displays typical images obtained during the implantation of left-
sided leads: (1) fluoroscopic and videoscopic images of the initial cannulation of the 
coronary sinus; (2) fluoroscopic and fiberscopic images of the subselection of a target 
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lateral vein; and (3) fluoroscopic, videoscopic, fiberscopic, and external images of a 
subsequently implanted left-sided lead. 
Figure A1.1 Visualization of an implantation of a left sided pacing lead in a 
reanimated human heart 
! "#!
Figure 8: Internal images of an LV lead implantation in swine. (1) Fluoroscopic and endoscopic images of the 
cannulation of the coronary sinus with a venogram balloon catheter (2) Fluoroscopic and fiberscopic images of 
the subselection of the target v in with an inner catheter (3) Fluoroscopic, fiberscopic, external, and 
endoscopic images of an implanted left-sided pacing lead in a lateral cardiac vein 
(1)  
(2)  
(3)  
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Conclusion: Using Visible Heart ® methodologies, we were able to obtain novel footage 
of left-sided lead implantations that are of educational value for students, patients, 
physicians, and left-sided lead device design engineers. 
 
Research Support: The University of Minnesota’s Institute for Engineering in Medicine 
and Medtronic Inc. (Minneapolis, MN) 
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A2. Left-sided Epicardial Pacing Via A Transvenous Lead Delivery 
Julianne H. Spencer, Ryan P. Goff, David G. Benditt, and Paul A. Iaizzo 
Published technical paper in the Journal of Medical Devices (2012) 6(1). 
 
Introduction 
Cardiac Resynchronization Therapy (CRT) is considered a useful therapy for heart 
failure patients with electromechanical dyssynchrony. To date, it has been reported that 
approximately 10-20% of heart failure patients (570,000-1.14 million people) will benefit 
from the placement of CRT [1]. The current approach of CRT is to pace the site of latest 
left ventricular activation [2-3]. The LV lead is typically implanted in a cardiac vein. 
However, approximately 30% of CRT patients do not clinically respond to the treatment 
[4-5]. In many cases, this is considered to be a result of suboptimal lead placement due to 
limitations of the cardiac venous anatomy. We propose here that it may be possible to 
overcome such limitations by perforating through the wall of the coronary sinus or great 
cardiac vein to gain access to the epicardial surface for optimal lead placement. 
 
Methods 
In order to test our proposed method, we employed the Visible Heart ® 
methodologies, which allows for a four chamber working swine heart preparation as 
described previously [6]. The University of Minnesota’s Animal Care and Use 
Committee approved all experimental protocols involved in this study. 
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First, we cannulated a given coronary sinus (CS) with a CS catheter (Attain, 
Medtronic Inc., Mounds View, MN). We then advanced a steerable inner catheter 
(Prevail, Medtronic Inc., Mounds View, MN) through the CS catheter and identified a 
target perforation site. The target perforation site will be the location within the CS or 
great cardiac vein that is close to the site of latest activation. Next, we advanced a stylet 
(Medtronic Inc., Mounds View, MN) through the lumen of the inner steerable catheter 
until it perforated the target venous perforation site. Then we advanced the inner steerable 
catheter over the stylet through the perforated vein and steered the catheter to the target 
pacing site.  
 
Results 
Figure A2.1 exhibits our proposed method.  
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Figure A2.1 Epicardial delivery of a pacing lead with a transvenous approach 
1(a) demonstrates perforation of the great cardiac vein with a stylet followed by the 
advancement of the inner catheter 1(b). Figure 1(c) displays access to the target pacing 
site with a steerable inner catheter. Figure 1(d) demonstrates a subsequent lead 
placement. 
 
 
 
Discussion 
We believe that these preliminary tests provide evidence that this epicardial lead 
placement technique is a feasible method to obtain access to optimal CRT pacing sites. 
There are a few factors that must be considered as we continue to develop this method. 
It is important to ensure that the stylet will perforate outwardly into the pericardial fluid 
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and not into any nearby arteries. The use of fluoroscopy should reduce this risk. There is 
also a risk for pericardial perforation; however, our preliminary in situ studies indicate 
that this risk is low. The risk of cardiac tamponade is minimized due to the low pressures 
in the veins and right atrium, but we plan to investigate this risk further. 
We will continue to perform further testing in an in situ swine model, with the 
pericardium intact. We will also look into various epicardial lead anchoring techniques 
once the optimal pacing position has been obtained. 
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A3. Imaging of a Coronary Artery Stent Implantation within an 
Isolated Human Heart 
Julianne H. (Eggum) Spencer, Stephen A. Howard, Ryan P. Goff, and Paul A. Iaizzo 
Published imaging paper in the Journal of Cardiovascular Translation Research (2012) 
5(1): 73-74 
 
Introduction 
Currently, over 16 million Americans have coronary artery disease (CAD). 
Consequently, almost 8 million Americans have suffered a myocardial infarction (MI). 
One method of treating CAD and MI is the implantation of an expandable stent within a 
compromised artery (for example, one partially occluded by atherosclerotic plaque). In 
2007 alone, approximately 560,000 Americans received a coronary stent implantation.1 
Novel imaging of the implantation of a coronary artery stent has potential 
educational benefits for physicians, design engineers, and patients to better understand 
such procedures and the devices. We employed Visible Heart® methodologies2 to obtain 
endoscopic footage of a coronary artery stent implantation within a reanimated human 
heart. This experimental approach provides unique imaging of the device-tissue interface 
that can be used for device development to address related issues, such as vessel 
perforation and stent dislodgement, which cannot be seen as well on fluoroscopy. The 
endoscopic imaging modality can then be used to evaluate emerging stent technologies. 
                                          
1American Heart Association. Heart disease and stroke statistics: 2011 update. Dallas, TX: American Heart 
Association, 2011. 
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Further, such images could be employed as useful training tools for cardiac 
interventionalists as well as educational means for explaining these procedures to 
patients. 
 
Method 
To obtain these images, we reanimated a human heart from an 18-year-old male 
organ donor whose heart was deemed non-viable for transplantation and whose family 
graciously provided this specimen for research. LifeSource (the Midwest organ 
procurement organization, St. Paul, MN) recovered and transported the heart at -4°C to 
our laboratory within 4 hours of when the heart was cross-clamped. We then cannulated 
the great vessels of the heart and placed it on the reanimation apparatus where it was 
rewarmed to 37°C and defibrillated so to elicit a native sinus rhythm. The Visible Heart® 
methodologies allow for a four chamber working heart preparation that perfuses a clear 
Krebs-Henseleit buffer through the chambers and vessels as described previously.2,3  
We obtained fluoroscopic images (Ziehm Imaging, Nuremburg, Germany) in an 
AP position and simultaneous endovascular images using a 2.4mm diameter fiberscope 
(Olympus, Center Valley, PA). We made a small incision in the left anterior descending 
artery (LAD) distal to the stent placement. We then advanced the fiberscope retrograde 
into the LAD to view the stent implantation procedure. 
 
                                          
2 Hill AJ, Laske TG, Coles JA Jr., Sigg DC, Skadsberg ND, Vincent SA, Soule CL, Gallagher WJ, Iaizzo PA. 
In vitro studies of human hearts. Ann Thorac Surg. 2005;79:168-177. 
3Chinchoy E, Soule CL, Houlton AJ, Gallagher WJ, Hjelle MA, Laske TG, Morissette J, Iaizzo PA. Isolated 
four-chamber working swine heart model. Ann Thorac Surg. 2000; 70(5):1607-14.	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Figure and Video Legend 
For stent deployment, we advanced a guidewire through the left coronary ostium 
to the LAD. A CordisBx Velocity Rx® balloon expandable stent (4.0mm inner diameter, 
23mm length) was advanced over a guidewire to the desired position within the LAD. 
The balloon was inflated to the manufacturer’s recommended pressure and then deflated. 
The catheter was then withdrawn and the fiberscope, which was positioned distal to the 
stent, was advanced retrograde through the expanded stent for inspection (this article has 
a supplemental video). 
Views of the expanded stent within the coronary artery are presented via three 
different imaging modalities (see Figure A3.1: (1) with fluoroscopy, (2) within the artery 
by the retrograde placement of a fiberscope, and (3) modeled within the coronary artery 
system). After we perfusion-fixed the heart in formalin, we obtained computed 
tomography (CT) images with contrast-injected coronary arteries. Subsequently, we 
modeled the placement of the stent with three-dimensional reconstructions employing 
MIMICs Software (Materialise, Leuven, Belgium) to better visualize the stent’s 
placement in the LAD relative to the other major cardiac arteries. (this article had a 
supplement video). 
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Figure A3.1 Fluoroscopic, fiberscopic, and computer model visualization of a 
coronary stent 
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A4. 3- Dimensional Reconstructions of the Human Coronary Artery 
System: using Contrast Computed Tomography of Perfusion-fixed 
Specimens 
Julianne H. Spencer, Matthew Venegoni, and Paul A. Iaizzo 
Published technical paper in the Journal of Medical Devices (2013) 
 
 
Introduction 
Coronary artery disease is the leading source of morbidity and mortality in 
developed countries [1]. Several transcatheter-delivered treatments have been developed 
to treat coronary artery disease, such as angioplasty and stent delivery devices. 
Understanding the anatomy of the coronary artery system is essential for the development 
of these devices. 
 In general, the coronary artery system is comprised of four major coronary 
arteries as displayed in Figure A4.1: the right coronary (RCA), left main coronary (LCA), 
left anterior descending (LAD), and circumflex (Cx) arteries. The RCA begins at the 
right coronary sinus in the aortic root. This vessel courses along the right atrioventricular 
groove. The LCA begins in the left coronary sinus and branches into the LAD and Cx. 
The LAD courses down the anterior interventricular groove and the Cx courses around 
the left atrioventricular groove. 
 The purpose of this study is to generate and assess 3-dimensional models of the 
coronary arteries for aid in the development of devices that utilize these vessels. 
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Figure A4.1 The major coronary arteries 
 
Methods 
We obtained coronary arterial maps from perfusion-fixed hearts. These specimens 
were obtained fresh through a collaboration with LifeSource (St. Paul, MN) from organ 
donors whose hearts were not considered viable for transplant. Hearts were perfusion-
fixed to elicit a relative end-diastolic state. 
 Subsequently, we cannulated the coronary artery ostia of a given specimen with 
two venogram balloon catheters. The heart was then placed into its anatomical position in 
a computed tomography (CT) scanner (Fairview, Minneapolis, MN). We injected 40mL 
of contrast into the arteries at 5mL/s and obtained computed tomography scans eight 
seconds after the initial injection, which were followed by a 30mL saline flush. 
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 The contrast-CT images (dicom files) were uploaded into Mimics Software 
(Materialise, Leuven, Belgium). Using the software, we reconstructed the coronary 
arteries. From these generated models, we measured the branching angle, arc length, 
tortuosity, number of branches, arc length of the artery with a diameter under 2mm, and 
ostial long and short axis diameters. Tortuosity was defined by the arc length divided by 
the linear distance from the beginning and end of a vessel. 
 To date, we have generated 27 reconstructions and measured various anatomical 
parameters of the coronary artery system. 
 
Results 
Figure A4.2 displays three of the generated arterial models from heart specimens 
associated with various cardiac disease states. Tables A4.1 and A4.2 present the median 
anatomical parameters measured for these specimens. The RCA was typically the longest 
and most tortuous vessel with the greatest number of emanating branches. As expected, 
the LCA was consistently the smallest and least tortuous vessel. Figure 3 summarizes 
several of the variations between hearts in arc length, tortuosity, and ostial short axis 
diameter using boxplots. We observed a high degree of variability in the arc length 
parameter and generally less variability in the tortuosity and ostial diameter parameters. 
The RCA was typically the most variable vessel in terms of the parameters studied here, 
while the LCA was the least. 
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Figure A4.2 Three coronary arterial models with varying disease states 
The red indicates coronary arteries from a heart with no history of cardiac disease, the 
brown indicates a reported history of coronary artery disease, and the pink indicates a 
reported history of hypertension. The models are presented in multiple views: (A) 
anterior view, (B) superior view, (C) right view, and (D) left view. 
 
 
 
Table A4.1 Median parameters for branching angle, arc length, tortuosity, and 
number of branches for 27 human hearts. 
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Table A4.2 Median parameters for ostial long and short axis diameters and arc 
length of the vessel with a diameter less than 2mm for 27 human hearts. 
 
 
Figure A4.3 Boxplots of the arc length, tortuosity, and ostial short axis diameter for 
27 human hearts 
A. Arc Length; B. Tortuosity; C. Ostial short axis diameter 
 
A.  
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B.  
C.  
 
Discussion 
The results of this study can be incorporated into the design of devices and 
respective delivery systems to be employed within the coronary artery system. However, 
it is important to note that our study approach can be considered to have a few 
limitations. For example, contrast was more easily injected in some hearts than others. 
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Some of the coronary branches may not have filled properly. Further, a relatively small 
sample size was investigated. However, we will continue to build this novel database of 
coronary artery anatomy using hearts from our unique human heart library, which 
currently contains over 250 specimens. Once our studied specimen numbers have 
increased appropriately, we plan to investigate these coronary anatomic features based on 
history of cardiac disease. 
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Appendix B: Mean and standard deviations of coronary 
venous anatomical parameters assessed for 11 specimens with 
a history of heart failure 
 
Table B.1 Coronary venous parameters for specimens with a history of heart failure 
pt presents the Wilcoxon p-value when comparing parameters from the 11 heart failure 
hearts to the total sample of 121 hearts. ph presents the Wilcoxon p-value when 
comparing the heart failure parameters to the parameters obtained from 34 specimens 
with no history of cardiac disease. P-values less than 0.05 were considered to be 
significant. Note that parameters for the small cardiac vein were not included in this table 
because only one of the specimens with a history of heart failure had a visible small 
cardiac vein. 
 
Vein 
Distance 
to the 
Coronary 
Sinus 
Ostium 
(mm) 
Branching 
Angle 
 (°) 
Arc Length 
(mm) Tortuosity 
Number 
of 
Branches 
Ostial 
Short 
Axis 
Diameter 
(mm) 
Ostial 
Long 
Axis 
Diameter 
(mm) 
Middle 
Cardiac Vein 
(MCV) n=11 
8.1 ± 6.9 
pt = 0.70 
ph = 0.93 
85.2 ± 10.1  
pt = 0.59 
ph = 0.23 
125.0 ± 24.3  
pt = 0.56 
ph =  0.49 
1.36 ± 0.20  
pt = 0.99 
ph = 0.54 
6.5 ± 6.0  
pt = 0.89 
ph = 0.85 
3.8 ± 1.6  
pt = 0.42 
ph = 0.45 
5.2 ± 1.6  
pt = 0.43 
ph = 0.47 
Inferior Vein 
(IV) n=9 
21.0 ± 8.4  
pt = 0.86 
ph = 0.37 
88.7 ± 9.4  
pt = 0.26 
ph = 0.18 
63.5 ± 25.2  
pt = 0.39 
ph = 0.28 
1.18 ± 0.10  
pt = 0.61 
ph = 0.65 
3.6 ± 2.7  
pt = 0.66 
ph = 0.65 
2.5 ± 0.9  
pt = 0.31 
ph = 0.80 
3.6 ± 1.4  
pt = 0.62 
ph = 0.83 
Inferolateral 
Vein (ILV) 
n=5 
32.3 ± 7.8  
pt = 0.07 
ph = 0.16 
93.8 ± 20.1  
pt = 0.86 
ph = 0.48 
74.4 ± 27.9  
pt = 0.35 
ph = 0.19 
1.20 ± 0.13  
pt = 0.91 
ph = 0.94 
5.0 ± 3  
pt = 0.13 
ph = 0.07 
3.9 ± 1.8  
pt = 0.26 
ph = 0.39 
4.6 ± 1.4  
pt = 0.22 
ph = 0.39 
Left Lateral 
Vein (LLV) 
n=18 
64.6 ± 9.5  
pt = 0.49 
ph = 0.88 
103.5 ± 24.4  
pt = 0.95 
ph = 0.71 
81.1 ± 34.1  
pt = 0.48 
ph = 0.22 
1.25 ± 0.13  
pt = 0.67 
ph = 0.72 
5.2 ± 4.1  
pt = 0.36 
ph = 0.18 
3.4 ± 1.1  
pt = 0.57 
ph = 0.78 
4.4 ± 1.5  
pt = 0.44 
ph = 0.32 
Anterolateral 
Vein (ALV) 
n=6 
82.8 ± 
10.0  
pt = 0.53 
ph = 0.17 
107.5 ± 28.8  
pt = 0.24 
ph = 0.07 
41.7 ± 22.8  
pt = 0.60 
ph = 0.69 
1.13 ± 0.06  
pt = 0.37 
ph = 0.15 
2.0 ± 3.5  
pt = 0.10 
ph = 0.13 
3.2 ± 0.8  
pt = 0.02* 
ph = 0.01* 
4.0 ± 0.8  
pt = 0.02* 
ph = 0.01* 
Anterior 
Interventricular 
Vein (AIV) 
n=11 
103.8 ± 
10.4  
pt = 0.50 
ph = 0.50 
146.8 ± 37.4  
pt = 0.25 
ph = 0.25 
121.6 ± 32.0  
pt = 0.70 
ph = 0.81 
1.33 ± 0.18  
pt = 0.72 
ph = 0.79 
8.6 ± 5.0  
pt = 0.63 
ph = 0.70 
4.0 ± 1.6  
pt = 0.19 
ph = 0.09 
4.7 ± 1.8  
pt = 0.16 
ph = 0.08 
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Appendix C: Comparing coronary sinus and left circumflex 
artery parameters between specimens with a history of various 
cardiac diseases 
 
 
Table C.1 Coronary sinus and left circumflex artery anatomical parameters as a 
function of location around the mitral valve annulus 
(Following page) Parameters are displayed as their means +/- standard deviations. The p-
values are derived from Wilcoxon rank sum analyses. P-values less than 0.05 are 
considered to be significant and are highlighted in bold text. 
 
 190 
 
 191 
Table C.2 Coronary sinus and left circumflex artery distance and corresponding 
angle that courses around the mitral valve annulus 
Parameters are displayed as their means +/- standard deviations. The p-values are derived 
from Wilcoxon rank sum analyses. P-values less than 0.05 are considered to be 
significant and are highlighted in bold text. 
 
